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ABSTRACT OF DISSERTATION

MOLECULAR MECHANISMS OF OLFACTORY NEURODEGENERATION

Olfactory sensory decline has been associated with normal aging as well as
neurodegenerative disorders, yet the underlying mechanisms are unclear. The overall aim
of this dissertation was to investigate the fundamental molecular and cellular mechanisms
associated with olfactory neurodegeneration. This investigation uses an integrative
approach, combining proteomics and gene expression analyses with cellular and tissuelevel characterization. Using these approaches, two model systems were investigated: 1)
normally aging C57BL/6 mice of ages 1.5-, 6- and 20-months; and 2) a mouse model of
elevated endogenous oxidative stress-associated neurodegeneration, namely, the
Harlequin mutant mouse. The first specific aim was to test the hypothesis that oxidative
stress is associated with aging of the olfactory system. Using proteomics, I demonstrated
that olfactory aging was accompanied primarily by increased oxidative stress-,
mitochondrial metabolism- and synaptic/transport-associated changes.

The second

specific aim was to test the hypothesis that the olfactory system accumulates oxidative
stress-mediated macromolecular damage over time, predisposing it to neurodegeneration.
Two types of protein oxidation, namely, carbonylation and nitration, accumulated with
aging in the olfactory system. Protein and cellular targets of oxidative stress-associated
damage were identified using redox proteomics coupled with immunohistochemical
localization. The third specific aim was to test the hypothesis that elevated oxidative
stress in the olfactory system results in apoptosis/neurodegeneration. The Harlequin
mutant mouse was critically selected and validated as a model for studies of oxidative

stress-associated olfactory neurodegeneration at both the cellular and molecular levels.
The Harlequin mouse had decreased levels and altered distribution of apoptosis inducing
factor protein in mature olfactory sensory neurons, increased oxidative DNA damage and
apoptosis in the olfactory epithelium, and pronounced cytoskeletal disorganization. The
molecular studies confirmed and extended our cellular data and identified several
significantly regulated genes associated with elevated oxidative stress and apoptosis.
This novel study, by combining contemporary proteomics and genomics with cellular and
tissue-level analyses, has provided a road map for understanding fundamental molecular
mechanisms of olfactory degeneration.
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CHAPTER ONE
INTRODUCTION

Olfactory impairment in aging and neurodegenerative diseases

“The quality, not the longevity, of one's life is what is important”
- Martin Luther King.
Neurodegeneration is one of the three themes of research interest in the NIH Blueprint for
Neuroscience Research. Olfactory impairment and anosmia (loss of sense of smell) have been
associated with aging in humans (Doty 1991b; Kovacs 2004; Murphy et al. 2002) as well as
with several aging-associated neurodegenerative disorders including Alzheimer’s (AD),
Parkinson’s and Huntington’s disease (Mesholam et al. 1998b). Over the years, a number of
neuroanatomical and immunohistochemical changes have been reported in the olfactory
epithelium (OE) and olfactory bulbs (OBs) in aging and aging-associated neurodegenerative
disorders, yet the precise molecular mechanisms underlying olfactory decline remain unclear.
Neurodegeneration has been associated with certain molecular and cellular processes that
include elevated oxidative stress/stress response; macromolecular damage including increased
DNA damage, protein oxidation, and lipid peroxidation; mitochondrial metabolic decline;
increased apoptosis; and increased inflammation.

Brain research over the past decade has

revealed that while neuronal loss by apoptosis seems to play a major role in neurodegenerative
disorders, it is unlikely to be a predominant factor in normally aging brain (Morrison and Hof
1997; Pollack and Leeuwenburgh 2001). Rather, subtle molecular changes, such as oxidative
stress-induced damage and mitochondrial impairments, appear to have a significant impact on
neuronal functional decline in aging brain (Poon et al. 2004a). It is possible that such functional
impairments serve to predispose the aging brain to further insults, leading to the dysfunction and
apoptosis that is characteristic of neurodegenerative disorders.
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Interplay of environment and bioenergetics: oxidative stress
Reactive oxygen species (ROS) and reactive nitrogen species (RNS) are potentially toxic
by-products of normal cellular oxidative metabolism, with mitochondria as both their primary
source as well as key target (Andersen 2004; Emerit et al. 2004). Examples of ROS are
superoxide (O2.), hydrogen peroxide (H2O2) and hydroxyl radical (HO.). RNS include nitric
oxide (NO) and its derivatives, such as peroxynitrite (-OONO; (Poon et al. 2004a). Throughout
life, these ROS and RNS are produced in metabolically active cells and are continuously
scavenged by endogenous antioxidants. This is critical because ROS and RNS can react with
proteins, lipids and nucleic acids, and consequently, result in damage of these macromolecules
(Poon et al. 2004a). Oxidatively damaged macromolecules may either be repaired or removed
from the cell by various cellular processes, including DNA repair mechanisms and the ubiquitinproteasome system. Under conditions of excessive ROS and/or RNS production or inadequate
antioxidant response, the cell is considered to be under “oxidative stress.” Oxidative stress can
result in the post-translational modification and damage of cellular proteins, lipids, and DNA.
Oxidative stress-associated macromolecular damage can be detrimental to the cell as a result of
undesirable and potentially catastrophic consequences, including mutations in DNA and RNA
which could predispose the cell to transformation and/or result in translation of
aberrant/misfolded proteins; disruption of active sites of enzymes and misfolding of structural
proteins; dysfunction of the ubiquitin-proteasome mechanism of protein disposal resulting in an
accumulation of oxidatively damaged proteins as aggregates; and disruption of cellular
membranes due to lipid peroxidation (e.g. reviewed by (Andersen 2004; Dalle-Donne et al. 2006;
Keller et al. 2004; Poon et al. 2004a). Cells have in-built mechanisms to sense redox imbalances
and either arrest their cell cycle and undergo senescence or trigger self-destruction by
programmed cell death (Dawson and Dawson 2004).
Oxidative stress is a major mediator of the progressive decline in cellular function during
aging in various tissues (Andersen 2004). In the aging brain, free radical-mediated oxidative
stress results in the oxidation of proteins, nucleic acids, and lipids, altering the structure and
function of these macromolecules (Beckman and Ames 1998; Levine and Stadtman 2001). For
example, protein carbonylation (see Figure 1.1), a type of protein oxidation, increases with aging
in a wide range of species and tissues, including human brain (Levine and Stadtman 2001).
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Increased protein oxidation has been associated with altered protein function and reduced
enzyme activity, leading to cellular dysfunction in aging brain as well as in age-related
neurodegenerative diseases (Andersen 2004; Butterfield and Stadtman 1997; Dalle-Donne et al.
2006). Interestingly, specific proteins appear to be targeted for oxidative modification during
aging and in several age-related neurodegenerative disorders, leaving other proteins unaltered
(Butterfield et al. 2003). In a collaborative pilot study of aging mice conducted by Dr. D. Allen
Butterfield’s and our laboratories, we recently demonstrated that total protein oxidation was
elevated in brains of old mice (Figure 1.2; (Poon et al. 2006b).

In this study we also

demonstrated that specific proteins were oxidized, which we identified using proteomics, and
that these oxidized proteins were functionally less active in brains of old mice (Poon et al.
2006b).

Whether one would observe similar changes in the OE and OB remained to be

investigated. The capacity for replacement of olfactory sensory neurons (OSNs) in the OE and
granule cells and periglomerular interneurons in the OB via neurogenesis may dampen the
effects of oxidative stress by removing and replacing neurons with extensive macromolecular
damage. Yet, unlike the brain, the OE is constantly exposed to environmental insults which
would significantly contribute to the oxidative stress in the olfactory system.

Cumulative

oxidative damage, both due to exogenous and endogenous insults, may alter the cellular
dynamics of this system and consequently lead to a functional decline of damaged cellular
targets, an increase in cell death and decrease in neurogenesis. Literature clearly substantiates
the involvement of oxidative stress in the olfactory system in aging and neurodegenerative
diseases and the uniqueness of this system suggests that the mechanisms of oxidative stress
associated cellular damage, death and antioxidant response may be different from those observed
in the brain.
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human lens

rat liver

human dermal fibroblasts
house fly

brain

Figure 1.1. (Modified from (Levine and Stadtman 2001). The graph shows the protein carbonyl
content from various tissues and species as a function of fraction of lifespan. The green dashed
line shows the trend towards increased protein carbonylation in aging human brain (clear
squares), which appears to be cumulative, unlike the biphasic change observed in other tissues.
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Figure 1.2. (From(Poon et al. 2006b). The graph shows the total protein carbonyl level in
brains of young and old C57BL/6 mice determined by slot blot analysis. The total carbonyl level
was significantly higher (~ 40%) in the brains of old mice when compared to young. Bars,
±S.E.M. *p < 0.05, n = five samples from young and five samples from old cohorts.
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Oxidative stress in olfactory aging and neurodegeneration
Oxidative stress is associated with aging and many age-related diseases. Reports from
our laboratory and others have shown the occurrence of oxidative stress in the olfactory system
in aging and neurodegenerative diseases such as AD (Chuah and Getchell 1999; Getchell et al.
2002a; Getchell et al. 2003a; Getchell 2002; Getchell et al. 2003b; Getchell 2001a; Getchell et al.
2003c; Getchell et al. 1995; Perry et al. 2003; Perry et al. 2000; Rama Krishna et al. 1995). The
reduction in levels of xenobiotic metabolizing enzymes (Krishna et al. 1995) and in the
expression of heat-shock protein 70 in human olfactory receptor neurons (Getchell et al. 1995)
with aging indicated that secretory and neuronal impairments in stress responses may contribute
to age-associated loss of olfactory function. Elevated cellular deposits of lipofuscin, the oxidized
protein-containing aging pigment (Terman and Brunk, 2006), was observed in the OE of aging
rats (Naguro et al. 1992), indicating oxidative stress. In AD patients, the protein oxidation index
3-nitrotyrosine (3-NT) was elevated in OSNs, further suggesting a direct involvement of
oxidative stress in olfactory impairment (Getchell et al. 2003b). In the OBs of elderly humans,
oxidative stress was evidenced by high levels of lipofuscin as well as the presence of numerous
microglia (Getchell 2001b; Getchell and Getchell 2002).
At the molecular level, alterations in gene expression have been reported by our group in
the OE of the senescence-accelerated mouse (SAM) model, including an up-regulation of genes
associated with oxidative stress, extracellular matrix and immunosenescence (Getchell et al.
1995; Getchell et al. 2003d).
Several intriguing unanswered questions remained, such as, whether the aging olfactory
system accumulated oxidative macromolecular damage, and if so, which specific proteins are
targets of oxidation in the olfactory system? Do targets of protein oxidation in the olfactory
system differ from those identified in our whole brain pilot proteomics study? Which cell types
are vulnerable to the effects of oxidative stress? Could we then simulate the physiological,
cellular and molecular changes observed in the aging olfactory system in an adult mouse model
with elevated endogenous oxidative stress?
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The need for a model of oxidative stress-associated olfactory degeneration
The evidence described clearly establishes oxidative stress as a major player in olfactory
impairment observed in aging and age-associated diseases. Various studies have investigated the
direct effects of exogenous oxidants on olfactory pathology and function (Genter et al. 2002) and
have contributed significantly to our understanding of the effects of these oxidants on olfactory
neurons. In contrast, few studies have addressed the role of endogenous oxidants, namely ROS
and RNS, derived from normal cellular metabolism, on the olfactory system.
Upon careful consideration of several available mouse models, I selected the Harlequin
mutant mouse for pilot studies of the role of endogenous oxidative stress in the olfactory system.
The Harlequin mutant mouse is a model of adult-onset neurodegeneration and carries an Xlinked recessive mutation in the Pdcd8 (programmed cell death 8) gene. The protein product of
Pdcd8 is known as apoptosis-inducing factor (AIF; (Klein et al. 2002; Susin et al. 1999). This
protein has dual physiological functions: first, the maintenance of normal mitochondrial
metabolism and consequently low levels of oxidative stress in neurons via its oxidoreductase
domain, and second, the induction of programmed cell death in a caspase-independent manner
via its apoptotic domain (Cheung et al. 2006; Modjtahedi et al. 2006). The Harlequin mouse
exhibits an 80% reduction in Pdcd8 mRNA and AIF protein expression, increased oxidative
stress, and mitochondrial bioenergetic impairment in several tissues including the brain and
retina (Klein et al. 2002). Mitochondrial bioenergetic decline, leading to increased ROS and
RNS production, is a hallmark of brain aging and age-associated neurodegenerative diseases
(Rego and Oliveira 2003; Sastre et al. 2003). DNA oxidation is elevated in the cerebellum and
retina of Harlequin mice, leading to increased mutations and apoptotic cell death of certain
neurons (Klein et al. 2002; Stringer et al. 2004; Vahsen et al. 2004). A schematic (from (Klein
and Ackerman 2003) of the proposed mechanism by which the Harlequin mutation leads to
elevated oxidative stress and apoptosis in neurons is shown in Figure 1.3. The characteristics
described above made the Harlequin mouse an attractive candidate for systematic studies of
oxidative stress and neurodegeneration in the olfactory system.
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Figure 1.3. (From (Klein and Ackerman 2003). Elevated oxidative stress leads to apoptosis in
the Harlequin mouse. The diagram shows a model showing the proposed events occurring in
neurons of Harlequin mutant mice, in which AIF levels are substantially reduced, leading to cell
death.
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Looking at the big picture: an integrative approach
“….though each was partly in the right, and all were in the wrong!” from The Blind Men
and the Elephant, by John Godfrey Saxe.
Our knowledge of any system is limited by the pieces of the puzzle available to us,
namely scientific data, and by our own interpretation. Scientific data is further limited by the
tools available to us for investigation and how we use them. In recent years, the availability of
many new methodologies along with computerization have expedited the process of gathering
data.

Various approaches, including genomics, proteomics and phenomics, have made it

possible to simultaneously investigate changes occurring in numerous molecules and cellular
pathways. Yet, surprisingly few studies have been reported in aging that integrate genomics,
proteomics and cellular analyses (Raghothama et al. 2005; Weinreb et al. 2007). In the olfactory
system, gene expression profiling has been used advantageously to unravel cell-type specific
gene expression in the mouse (Yu et al. 2005), apoptosis and tissue remodeling (Getchell et al.
2006; Shetty et al. 2005), neuro-immunological interactions (Getchell et al. 2006; Kwong et al.
2004), senescence-associated gene regulation (Getchell et al. 2004; Getchell et al. 2003d), and
tissue differences in gene expression in AD brains (Li et al. 2004).

In contrast, to our

knowledge, no proteomics studies have been reported in the olfactory system prior to the results
reported in this dissertation. While transcriptional analyses alone have provided a wealth of
information, in order to truly understand the role of oxidative stress-associated degenerative
changes in the olfactory system, a physiologically relevant integrative approach would be
essential. In this study I have used a combination of proteomics, redox proteomics and gene
expression analyses, complemented with cellular localization and tissue characterization. Using
these approaches, I investigated two model systems: 1) normally aging C57BL/6 mice of ages
1.5-, 6- and 20-months; and 2) a mouse model of elevated endogenous oxidative stressassociated neurodegeneration, namely, the Harlequin mutant mouse.
This dissertation, which combines contemporary proteomics and genomics with cellular
and tissue-level analyses to obtain a comprehensive “systems level” understanding of olfactory
degeneration, is unique in the olfactory neurobiology field. I hope that this novel approach will
serve as a kindling for future integrative studies of olfactory neurodegeneration.
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Specific aims
The overall aim of my dissertation was to investigate molecular and cellular mechanisms
associated with olfactory neurodegeneration.
Specific aim 1 was to test the hypothesis that oxidative stress is associated with aging of
the olfactory system.

The results of my first specific aim were published in the paper:

“Proteomic identification of differentially expressed proteins in the aging murine olfactory
system and transcriptional analysis of the associated genes.” H.F. Poon, R.A. Vaishnav (cofirst author), D.A. Butterfield, M.L. Getchell, T.V. Getchell; J. Neurochem. 2005; 94, 380–392.
These results were also presented at the Association for Chemoreception Sciences meeting in
April, 2005.
Specific aim 2 was to test the hypothesis that the olfactory system accumulates oxidative
stress-mediated macromolecular damage over time, predisposing it to neurodegeneration. The
results of my second specific aim were published in the paper: “Oxidative stress in the aging
murine olfactory bulb: redox proteomics and cellular localization.” R.A. Vaishnav, M.L.
Getchell, H.F. Poon, K.R. Barnett, W.M. Pierce, J.B. Klein, S.A. Hunter, D.A. Butterfield, T.V.
Getchell; J. Neurosci. Res., 2007; 85(2):373-85. These results were also presented at the
Association for Chemoreception Sciences meeting in April, 2006.
Specific aim 3 was to test the hypothesis that elevated oxidative stress in the olfactory
system results in apoptosis/neurodegeneration.

The results of my third specific aim were

submitted for peer review on April 4, 2007 to Journal of Neuroscience Research in a manuscript
titled: “Cellular and molecular characterization of oxidative stress in the olfactory
epithelium of the Harlequin mutant mouse.” R.A. Vaishnav, M.L. Getchell, L. Huang, M.A.
Hersh, A.J. Stromberg, T.V. Getchell.
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CHAPTER TWO
PROTEOMIC IDENTIFICATION OF DIFFERENTIALLY EXPRESSED PROTEINS IN
THE AGING MURINE OLFACTORY SYSTEM AND TRANSCRIPTIONAL ANALYSIS
OF THE ASSOCIATED GENES
#

H. Fai Poon1, #Radhika A. Vaishnav2, D. Allan Butterfield1,3,4*, Marilyn L. Getchell3,5, Thomas

V. Getchell2,3*
#

Note: H. Fai Poon and Radhika A. Vaishnav were co-first authors.

1

Department of Chemistry, University of Kentucky, Lexington, KY 40506

2

Department of Physiology, University of Kentucky, Lexington, KY 40536

3

Sanders Brown Center on Aging, University of Kentucky, Lexington, KY 40536

4

Center of Membrane Sciences, University of Kentucky, Lexington, KY 40506

5

Department of Anatomy and Neurobiology, University of Kentucky, Lexington, KY 40536

J Neurochem. 2005 Jul;94(2):380-92.
Note: In the Results section of Chapter Two, I, Radhika Vaishnav, contributed 100% to the
research shown in Figures 2.1, 2.5, 2.9 and 2.10; 50% to the research shown in Figures 2.2, 2.3,
2.6 and 2.7; and 10% to the research shown in Figures 2.4 and 2.8.
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Introduction
Olfactory impairment and anosmia (loss of sense of smell) have been associated with
aging in humans (Doty 1991b; Murphy et al. 2002) as well as with several age-associated
neurodegenerative disorders including Alzheimer’s and Parkinson’s diseases (Mesholam et al.
1998b). Many neuroanatomical and immunohistochemical changes have been documented in the
olfactory epithelium (OE) and olfactory bulbs (OB) of aging humans. These include a reduction
in surface area and an increase in susceptibility to neuronal apoptosis in the OE and a reduction
of OB size and cell number (Kovacs 2004). In the human OE, reduced adrenergic innervation of
blood vessels and glands (Chen et al. 1993) suggested impaired vasomotor and secretory
responses. The age-related reduction in levels of xenobiotic metabolizing enzymes (Krishna et
al. 1995) and in HSP70 expression by human olfactory receptor neurons (Getchell et al. 1995)
indicated that secretory and neuronal impairments in stress responses may also contribute to the
loss of olfactory sensibility with age. In the OB of elderly humans, high levels of lipofuscin as
well as the presence of numerous microglia, occasional β-amyloid fibrils and rare neurofibrillary
tangles were observed (Getchell 2001b; Getchell and Getchell 2002).
Molecular alterations in the aging murine olfactory epithelium have been reported at the
transcriptional level in OE of senescence-accelerated mouse models (Getchell et al. 1995;
Getchell et al. 2003d), where there was a down-regulation of PI3-kinase and ERK signaling, upregulated oxidative stress indicators, possible disruption of the extracellular matrix and a marked
immunosenescence. However, the precise molecular changes occurring in the normally aging
murine olfactory system, both at the protein and transcriptional level, have not been reported
previously. In this study, we utilized an unbiased fundamental proteomic analysis as a discoverybased method to identify differentially expressed proteins in the aging OE and OB. We report
significant molecular changes in the aging murine OE and OB at the protein and transcriptional
levels. This study provides a basis on which to formulate future hypothesis-driven experiments to
determine the mechanisms by which the differentially expressed proteins are modulated in aging.
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Materials and Methods

Animals and tissue harvesting from old and young mice
A total of 16 C57BL/6 male mice were obtained from Harlan, US and were of two ages:
the first group consisted of eight 80-week old mice (“old mice”) that were maintained as part of
the National Institute on Aging Aged Rodent Colonies, and the second group consisted of eight
6-week old mice (“young mice”). Six week old mice were chosen for this study as they are
sexually mature, young adults with a functionally fully-developed olfactory system. The mice
were maintained in an animal facility at the Department of Laboratory Animal Research on a 12
h light:dark cycle in Bioclean units with sterile-filtered air and provided food and water ad
libitum. All protocols were implemented in accordance with NIH guidelines and approved by
the University of Kentucky Institutional Animal Care and Use Committee. The body weights for
the old mice ranged from 32 to 35 g and for the young mice from 19 to 24 g. Following
euthanasia with CO2, microdissection was performed to isolate the OE and the OB following a
procedure previously reported (Getchell et al. 2004; Getchell et al. 2002c).

Immediately

following tissue harvesting, the tissues were weighed and snap frozen in liquid N2. For the old
mice, the OE weight (mean + SD) was 24.5 + 8.3 mg and for the OB was 32.6 + 3.3 mg; for the
young mice, the average OE weight was 13.8 + 2.3 mg and for the OB was 25.4 + 5.3 mg. The
OEs and OBs from five old and five young mice were used for proteomic analysis; the OEs and
OBs from three old mice and three young mice were used for RNA extraction and subsequent
real-time RT-PCR.

Proteomics sample preparation
The OE and OB samples were homogenized in a lysis buffer (10 mM HEPES, 137 mM
NaCl, 4.6 mM KCl, 1.1 mM KH2PO4, 0.6 mM MgSO4 and containing the protease inhibitors
leupeptin (0.5 mg/mL), pepstatin (0.7µg/mL), trypsin inhibitor (0.5 µg/mL), and PMSF (40
µg/mL)). Homogenates were centrifuged at 15,800 g for 10 min to remove debris. The
supernatant was extracted to determine the concentration by the BCA method (Pierce, Rockford,
IL, USA).
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Two-dimensional gel electrophoresis
Samples of the proteins in the OE and OB were prepared as previously described (Poon
et al. 2004b). Five individual 2D gels for OE of old mice and five individual 2D gels for OE of
young mice (for a total of ten) were run. Similarly, a total of ten 2D gels were run for OB.
Briefly, 200 μg of protein were applied to a pH 3-10 ReadyStrip™ IPG strip (Bio-Rad, Hercules,
CA) for isoelectric focusing (IEF), based on the pI or isoelectric pH of the protein. The focused
IEF strip was stored at –80oC until second dimension electrophoresis was performed. For second
dimension electrophoresis, Linear Gradient (8-16%) Precast criterion Tris-HCl gels (Bio-Rad,
Hercules, CA) were used to separate proteins according to their molecular weight (MrW).
Precision ProteinTM Standards (Bio-Rad, Hercules, CA) were run along with the samples. After
electrophoresis, the gels were incubated in fixing solution for 20 min. Sypro Ruby stain were
used to stain the gels for 2 hours. The gels were placed in deionized water overnight for
destaining.

Image analysis
The gels were scanned and saved in TIF format using a Storm 860 Scanner (Molecular
Dynamics). PDQuest (Bio-Rad, Hercules, CA) was used for matching and analysis of visualized
protein spots among differential gels. The principles of measuring intensity values by 2D
analysis software are similar to those of densitometric measurement. To determine the amount
of protein per spot, the intensity of the average background of the entire gel was subtracted from
that of each spot for normalization. This was repeated for each gel. After completion of spotmatching, the normalized intensity of each protein spot from five individual gels from the two
cohorts was compared between groups using a two-sample Student’s t-test. Only spots with pvalues < 0.05 were selected for trypsin digestion. Similar analyses were done for both OE and
OB.

Trypsin digestion
Samples were digested using the techniques previously described (Poon et al. 2004b)
Briefly, the selected protein spots were excised and washed with ammonium bicarbonate
(NH4HCO3), then acetonitrile at room temperature. The protein spots were incubated with
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dithiothreitol, then iodoacetamide solutions. The gel pieces were digested with 20 ng/µl modified
trypsin (Promega, Madison, WI) in 25 mM NH4HCO3 with the minimal volume to cover the gel
pieces. The gel pieces were chopped into smaller pieces and incubated at 37°C overnight in a
shaking incubator.

Mass spectrometry
Digests (1 μL) were mixed with 1 μL α-cyano-4-hydroxy-trans-cinnamic acid (10
mg/mL in 0.1% TFA:ACN, 1:1, v/v). The mixture (1 μL) was deposited onto a fast evaporation
nitrocellulose matrix surface, washed twice with 2 μL 5% formic acid, and analyzed with a
TofSpec 2E (Micromass, UK) MALDI-TOF mass spectrometer in reflectron mode. The mass
axis was adjusted with trypsin autohydrolysis peaks (m/z 2239.14, 2211.10, or 842.51) as lock
masses. The MALDI spectra used for protein identification from tryptic fragments were searched
against

the

NCBI

protein

databases

using

the

MASCOT

search

engine

(http://www.matrixscience.com). Peptide mass fingerprinting used the assumption that peptides
are monoisotopic, oxidized at methionine residues and carbamidomethylated at cysteine residues
(Castegna et al. 2002a);(Castegna et al. 2003);(Castegna et al. 2004). Up to one missed trypsin
cleavage was allowed. Mass tolerance of 150 ppm was the window of error allowed for matching
the peptide mass values.

Protein identification
All the mass spectra (not shown) of the peptides were matched to the mass spectra in
MSDB protein databases. A probability-based Mowse score was assigned for each protein
identified to indicate the probability that the match between the database and the experimental
protein is a random event. Scores greater than 61 were considered significant. Thus, if a match
has a score higher than 61, the match has a probability lower than 0.05. All protein
identifications agreed with the expected MrW and pI range based on their positions on the gel.

Immunochemical analysis
The linearity of the anti-cyclophilin A (PPIA) and anti-ferritin heavy chain (FTH1)
antibodies was measured by loading different amounts of protein from mouse tissue (OE for
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PPIA and OB for FTH1) into the slots. Briefly, 2 μL of the samples (2 μg/μL) were treated with
an equal volume of Laemmli buffer (0.125M Trizma base, 4%SDS, 20% glycerol) for 20
minutes. Levels of PPIA and FTH1 were measured by slot-blot with 1 μg of protein from OE or
OB per slot, respectively. The slot blots were detected on the nitrocellulose paper using a
primary rabbit anti-cyclophilin A antibody (1:500, UpState, Lake Placid, NY) or anti-FTH1
antibody (1:500, Alpha-Diagnostic, San Antonio, TX) and then a secondary anti-mouse IgG
(Sigma, St. Louis, MO) antibody. The resultant stain was developed by application of SigmaFast 5-bromo-4-chloro-3-indolyl phosphate/nitro blue tetrazolium (BCIP/NBT) tablets followed
by density measurement by Scion-Image software package (Scion, MD).

RNA extraction from mouse OE and OB tissue and reverse transcription (RT)
RNA was extracted from OE and OB tissues harvested from three old and three young
mice. Frozen tissue was homogenized in 1 ml of Tri-reagent using a sterile, RNase-free dounce.
The tissue was further disrupted using a Qiashredder column (Qiagen, Inc., Valencia, CA) as per
the manufacturer’s protocol. RNA was extracted according to the TRI-reagent method
(Molecular Research Center, Inc., Cincinnati, OH) and was further purified as per the Qiagen
RNeasy mini kit RNA Cleanup Protocol (Qiagen, Inc., Valencia, CA). The concentration and
quality of the RNA were assessed by spectrophotometry (Beckman Coulter, Inc., Fullerton, CA)
and with a Bioanalyzer (Agilent Technologies, Palo Alto, CA). Reverse transcription was
performed as per the protocol for the GeneAmp RNA PCR kit (Applied Biosystems, Inc., Foster
City, CA).

Primer design
For real-time PCR validation studies, we used the following primer sequences (forward
primer; reverse primer; annealing temperature; reference):
OE: Aco2 [tgggtggtgattggagatga; atctgggtctcgttgaaggt; 53 C; (Tabuchi et al. 2003)]; Aldh2
[acctggataaagccaatt;

tacccagtttatcaggagc;

50

C;

(Rout

and

Armant

2002)];

Ppia

(ccagggtggtgactttacac; cggaaatggtgatcttcttg; 53 C; MGI:3026778).
OB: Mdh1 (tggaccacaaccgagcaaa; tccccagataatgacattctttacatc; 55 C; Primer Express); Eno1
(tattgcgcctgctcggtta; tccatctcgatcagcttgt; 55 C; Primer Express); Dnm1 (atgccctcaagatcgctaagg;
cgtcccgcgcatctgt; 55 C; Primer Express); Fth1 [(gatcaacctggagttgtatgcc; gatattctgccatgccagcttc;
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55 C; (Carper et al. 2001)]; Atp5a1 (tggtggaattctcttcaggtta; ccaaacacgacaactccaacatt; 55 C;
Primer Express); Omp [gacattcttctagctgctcc; cagctttggccagcaggg, 55 C, (Buiakova et al. 1994)].
All primer pairs spanned at least one intron, with the exception of Omp (an intronless gene), to
allow for distinction of mRNA from possible genomic DNA amplification.

Real-time polymerase chain reaction
A cDNA amount equivalent to 10 ng total RNA per well was used for real-time PCR
analysis. Experimental samples, standards and no-template controls were all run in triplicate.
Standard curves were plotted for standards with concentrations of cDNA equivalent to 10 ng, 5
ng, 3.75 ng and 2.5 ng of RNA. Each reaction mix (one well) consisted of 1× QuantiTect SYBR
Green PCR Master Mix, cDNA, DEPC water, and 300 nM each of forward and reverse primers.
The real-time PCR reaction was carried out on a ABI Prism 7000 (Applied Biosystems, Inc.)
using the following parameters: 50 °C for 2 min; 95 °C for 15 min; 40 cycles of 94 °C for 15 s,
specific primer annealing temperature (see Primer design) for 30 s, and 72 °C for 1 min. Finally,
a dissociation protocol was also run at the end of each run to verify the presence of a single
product with the appropriate melting point temperature for each amplicon. To further ascertain
the specificity and size of the PCR products, the products were run alongside molecular weight
markers on a 2% agarose gel in 1xTAE at 100V for 50 min. The gel was stained with ethidium
bromide (Sigma) and visualized using UV light.
The data were analyzed by setting a specific threshold for each gene at the approximate
midpoint of the exponential phase of amplification using the methodology reported by Kwong et
al., 2004. The resultant threshold cycle (CT) values for each of the three biological replicates
were averaged.

Control and experimental conditions were evaluated statistically using an

unpaired t-test. Standard curves were generated for each gene of interest and R2 values were
calculated and verified to be >0.90 for all the genes studied. Using the standard curves, CT values were converted to relative amounts of cDNA; the change in CT value inversely correlates
with the direction of change of gene expression.
An unpaired t-test was carried out to determine the statistical significance of differences in the
expression of each gene between the young and old mice, and fold changes were calculated.
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Results

Proteomic analysis of the aging olfactory epithelium
In comparison to OE of young mice, the OE of old mice had 9 proteins that were
differentially expressed (7 up- and 2 down-regulated; Figure 2.1, left). Seven of the 9 proteins
matched the protein database with statistical confidence, and 6 of the 7 had protein names
assigned to their accession numbers. Figure 2.2 shows representative gels for the OE from old
and young mice. The proteins that were expressed differentially in the OE of old vs young mice
are summarized in Table 2.1. Figure 2.3 shows the relative expression levels of these nine
proteins in the OE of old mice as compared to that of young mice. Aldolase 1 (ALDO1),
cyclophilin A (peptidyl prolyl isomerase A or PPIA), mitochondrial aconitase 2 (ACO2), an
unnamed protein product (spot number 8007) and two unidentified proteins (spot numbers 405
and 6401) were up-regulated; and mitochondrial aldehyde dehydrogenase 2 (ALDH2) and
albumin 1 (ALB1) were both down-regulated in the OE of the old mice as compared to that of
the young mice. The identified proteins are listed in Table 2.2.

Immunochemical validation of PPIA
To demonstrate confidence in the proteomic identification of proteins in the OE and to
confirm the proteomic data for PPIA, we carried out immunochemical analysis using slot-blot
technology. We showed that our antibody-antigen reaction was linear (Figure 2.4, top) and that
the level of PPIA was significantly greater (1.3 fold) in the OE of old mice when compared to
that of the young mice (Figure 2.4, bottom). This concurs with the proteomic data.
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Figure 2.1. Flowchart illustrating experimental design and progression.
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Figure 2.2. Two-dimensional gel electrophoresis of OE protein. Representative 2D gels of
proteins from OE of young and old mice (left); expanded images of protein spots that are
significantly different (p < 0.05) between the young and old mouse OE (right).
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Figure 2.3. Proteins present in significantly different amounts in the OE of young and old mice.
Proteins expressed at significantly (p<0.05) different levels in the OE of old mice (n=5) relative
to young (n=5) are shown as % of young. Error bars represent standard errors.
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Table 2.1. Spot densities of proteins expressed at
significantly different levels (p<0.05) in OE
Spot
no. Young ±SE
507 100 27.76
1006 100 14.57
1802 100 25.89
2802 100 23.24
5602 100 7.87
6702 100 9.00
8007 100 7.06
405 100 23.18
6401 100 22.28

Old
330.29
168.40
297.02
205.87
75.81
55.75
182.24
270.35
244.61

±SE
64.64
13.99
64.78
26.10
5.40
13.10
22.67
68.91
55.72

p-value
1.13E-02
9.57E-03
2.23E-02
1.63E-02
3.49E-02
2.38E-02
8.52E-03
4.72E-02
4.25E-02

FC
3.3
1.7
3.0
2.1
1.3
1.7
1.8
2.7
2.4

Mean protein spot densities for the OE of old mice (n=5)
are shown here as % of young (n=5); SE, Standard
Error; FC, fold change; shaded cells, proteins less
abundant in old OE relative to young.

22

Table 2.2.

Spot no.
507
1006
1802
2802
5602
6702

Differentially expressed proteins identified in the OE.

Identified proteins
aldolase 1
cyclophilin A
mitochondrial aconitase 2
mitochondrial aconitase 2
mitochondrial aldehyde
dehydrogenase 2
albumin 1

%
Accession Mowse sequence
no.
Score coverage
gi|42490830
62
17
gi|6679439
83
34
gi|18079339
68
15
gi|18079339 140
22
gi|6753036
gi|33859506

94
234

23
48

No. of
peptide
match
6
7
10
16

MrW
39.4
18.1
86.2
86.2

pI
8.5
7.7
8.1
8.1

10
26

27.0
70.7

7.5
5.8

Proteins were trypsinized and analyzed by Mass Spectrometry in order to ascertain their
identities. Proteins with a Mowse score ≥ 61 were considered to be identified at a statistically
significant level. Shaded cells, proteins less abundant in old vs. young OE; MrW, molecular
weight; pI, isoelectric pH.
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Figure 2.4. Immunochemical analysis by slot blot of cyclophilin A (PPIA) protein in OE of
young and old mice. (Top) Anti-PPIA antibody showed linearity (R2 > 0.95) against different
amounts of PPIA in slot blots. (Bottom) The PPIA in OE of old mice is significantly higher (p <
0.05) than that in OE of young mice.
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Transcriptional analysis of selected proteins in the aging olfactory epithelium
Based on their relevance to aging and the proteomics findings, the genes selected for
transcriptional analysis of the OE were Aco2, Ppia and Aldh2. Of these, Aco2 and Aldh2, for
example, are both mitochondrial enzymes involved in metabolism and in the maintenance of
intracellular homeostasis. Aco2 is a TCA cycle enzyme that is a specific target of mitochondrial
oxidative stress during aging while Aldh2 is proposed to protect cells against oxidative stress.
The third gene chosen for transcriptional analysis by real time RT-PCR was Ppia, which has
been shown to be a protector against oxidative stress. The gene Aldo1, which is associated with
aging and oxidative stress as well, was not chosen for transcriptional analysis as it exists in
multiple isoforms in mouse tissues. Although ALB1 protein was also identified and found to be
down-regulated in the old OE, the lower levels of ALB1 may reflect a reduced blood flow or
constricted blood vessels in the OE with aging, or, alternatively, its identification could also be a
sampling artifact of obtaining highly vascularized tissue, and hence it was not selected for
transcriptional analysis.
Real-time RT-PCR was carried out using RNA extracted from OE of 3 young and 3 old
mice for the genes Aco2, Ppia and Aldh2 as well as Omp (olfactory marker protein). The
resultant amplification curves were plotted and the CTs were determined (Figure 2.5). Using
standard curve analysis, relative quantities were calculated for OE genes from old and young
mice, based on their relative mean CT values. The specificity of the PCR reaction was confirmed
by (a) matching the amplicon melting temperature obtained by dissociation curve analysis to the
calculated melting temperature (Figure 2.5, insets 1-3) and (b) the presence of a single band of
correct size on an ethidium bromide-stained 2% agarose gel (Figure 2.5., inset 4).
Based upon the real-time RT-PCR analysis, the transcripts for Aco2 was determined to be
present and significantly (p<0.05) up-regulated 1.4-fold in the OE of old mice as compared to
young (Table 2.3). This up-regulation was in concordance with the increase in the protein level
of ACO2 in the aged OE. The transcripts for Ppia and Aldh2 were expressed in the OE but
showed no significant difference between old and young mice. Aldh2 transcripts were relatively
considerably less abundant (higher CT ) compared to other genes in this study. Omp mRNA,
which is expressed in mature olfactory receptor neurons (Buiakova et al. 1994) and is used as an
internal standard for OE, was highly abundant in both old and young mice and was significantly
down-regulated 1.3-fold in the old compared to young OE (Figure 2.5).

25

Figure 2.5. Relative expression of mRNAs in OE.
Real time RT-PCR data for three of the proteins identified in the proteomic analysis, Aco2,
Aldh2, Ppia as well as for Omp, show the relative amplification of mRNA from OE of 3 young
and 3 old mice; reactions were done in triplicate. Insets in first three graphs, dissociation curve
confirming the presence of a unique PCR product; inset in Omp graph shows 2% agarose gel of
real-time RT-PCR products for Aco2, Aldh2 and Ppia (lanes 2-4).
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Table 2.3.

Comparison of results of real time RT-PCR and proteomics in OE.

Gene name

Young
CT

Old
CT

p -value

Aco2
Aldh2
Ppia

23.0±0.1
29.9±0.7
20.0±0.3

22.5±0.5
30.1±0.9
20.3±0.7

1.78E-02
8.18E-01
1.87E-01

FC (RNA)
FC (Protein)
Old vs Young Old vs Young
1.4
NSD
NSD

2.0
1.3
1.7

Mean protein spot densities for the OB of old mice (n=5) are shown as % of young
(n=5); SE, Standard Error; FC, fold change; shaded cells, proteins less abundant in
old OB relative to young. cDNA from OE of 3 old mice vs. 3 young mice were
analyzed (3 technical replicates per mouse); CT, cycle threshold, is expressed as
mean ± standard deviation; bold indicates p < 0.05 and concordance in the
directions of fold change of the protein and mRNA; NSD, no significant difference.

27

Proteomic analysis of the aging olfactory bulb
In comparison to OB of young mice, the OB of old mice had 20 proteins that were
differentially expressed (Figure 2.1), of which 6 matched the protein database with statistical
confidence. Figure 2.6 shows the representative gels from OB of old and young mice. The
proteins that were expressed differentially in the OB of old vs young mice are summarized in
Table 2.4. In Figure 2.7, we have shown the relative expression of these 20 proteins in OB of old
mice as compared young mice. ATP synthase isoform 1 (ATP5A1), enolase 1 (ENO1), ferritin
heavy chain (FTH1), malate dehydrogenase 1 (MDH1), tropomyosin alpha 3 chain (TPM3) and
10 non-identified proteins (spot numbers 109, 110, 1102, 1501, 1605, 1702, 4204, 4901, 5302,
5506, 6106) were up-regulated; and dynamin-1 (DNM1) and four other proteins (spot numbers
504, 2704, 4201 and 6204) that were not identified were down-regulated in OB of the old mice
as compared to the young mice. Table 2.5 lists the proteins identified.

Immunochemical validation of FTH1
To demonstrate confidence in the proteomic identification of proteins in the OB and to
confirm the proteomic data for FTH1, we carried out immunochemical analysis using slot-blot
technology. We demonstrated that the antibody showed linearity against FTH1 (Figure 2.8, top)
and that the level of FTH1 was significantly higher (2.7 fold) in the OB of old mice than of
young mice (Figure 2.8, bottom). This concurs with the proteomic data.
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Figure 2.6. Two-dimensional gel electrophoresis of OB protein.
Representative 2D gels of proteins from OBs of young and old mice (left); expanded images of
protein spots that are significantly different (p < 0.05) between the young and old mouse OB
(right).
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Figure 2.7. Proteins present in significantly different amounts in the OB of young and old mice.
Proteins expressed at significantly (p<0.05) different levels in the OB of old mice (n=5) relative
to young (n=5) are shown as % of young. Error bars represent standard errors.
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Table 2.4.

Spot densities of proteins expressed at

significantly different levels (p<0.05) in OB.
Spot no.
109
110
504
604
1102
1501
1605
1702
2704
3802
4201
4204
4503
4901
5104
5302
5506
6106
6204
7206

Young
100
100
100
100
100
100
100
100
100
100
100
100
100
100
100
100
100
100
100
100

±SE
128.6
87.1
12.3
21.0
17.6
61.7
46.1
53.3
5.9
9.3
4.5
25.9
38.1
61.6
28.5
33.8
31.6
81.2
8.0
32.8

Old
541.5
572.4
51.5
187.9
173.9
332.2
265.4
256.8
42.3
58.1
62.7
212.7
234.7
295.8
242.3
191.1
255.9
361.7
34.1
290.7

±SE
24.8
21.9
11.9
25.8
13.3
26.2
31.5
23.4
13.7
11.2
11.4
15.5
15.8
14.1
33.2
10.0
20.5
36.2
19.8
35.2

p- Value FC
9.77E-03 5.4
7.66E-04 5.7
2.17E-02 2.0
2.95E-02 1.9
1.00E-02 1.7
8.51E-03 3.3
1.81E-02 2.7
2.74E-02 2.6
4.75E-03 2.5
2.08E-02 1.7
1.61E-02 1.7
5.75E-03 2.1
1.14E-02 2.3
1.47E-02 3.0
1.16E-02 2.4
3.24E-02 1.9
3.26E-03 2.6
1.86E-02 3.6
1.50E-02 3.3
4.14E-03 2.9

Mean protein spot densities for the OB of old mice
(n=5) are shown as % of young (n=5); SE,
Standard Error; FC, fold change; shaded cells,
proteins less abundant in old OB relative to young.
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Figure 2.8. Immunochemical analysis by slot blot of ferritin heavy chain protein in OB of
young and old mice. (Top) Anti-ferritin antibody showed linearity (R2 > 0.95) against different
amounts of ferritin H (FTH1) chain in slot blots. (Bottom) The FTH1 in OB of old mice is
significantly higher (p < 0.05) than that in OB of young mice.
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Transcriptional analysis of selected proteins in the aging olfactory bulb
In order to gain insight into the mechanism(s) of regulation of the differentially expressed
proteins, we selected several proteins of known function and of relevance to our study for
transcriptional analysis; these were Atp5a1, Eno1, Fth1, Mdh1 and Dnm1 as well as Omp using
real-time RT-PCR analysis (Figure 2.9). The specificity of the PCR reaction was confirmed by
(a) matching the amplicon melting temperature obtained by dissociation curve analysis to the
calculated melting temperature (Figure 2.9, insets 1-5) and (b) the presence of a single band of
correct size on an ethidium bromide-stained 2% agarose gel (Figure 2.5., inset 6). We determined
that the transcripts for Fth1 were present and significantly (p<0.05) up-regulated 1.1-fold in the
OB of old mice compared to the young (Table 2.6). This is in concordance with the proteomic
data. In contrast, the transcripts for Dnm1, Mdh1, Atp5a1 and Eno1, while present, were not
significantly different between the old and young mouse OBs. As anticipated, Omp mRNA was
expressed at a much lower level overall in the OB than in OE, and was not differentially
expressed between old and young mouse OBs (Figure 2.9).
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Figure 2.9. Relative expression of mRNAs in OB.
Real time RT-PCR data for five of the proteins identified in the proteomic analysis of OB,
Atp5a1, Fth1, Dnm1, Mdh1, Eno1, as well as Omp, shows the relative amplification of mRNA
from OB of 3 young and 3 old mice; reactions were done in triplicate. Insets in the first 5 graphs,
dissociation curve confirming the presence of a unique PCR product; inset in Omp graph shows a
2% agarose gel electrophoresis of real-time RT-PCR products for Mdh1, Eno1, Dnm1, Fth1,
Atp5a1 and Omp (lanes 2-7).
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Table 2.5.

Spot no.
604
3802
4503
5104
5302
7206

Differentially expressed proteins identified in the OB.

Identified proteins
ATP synthase isoform 1
dynamin-1
enolase 1
ferritin heavy chain
malate dehydrogenase 1, NAD (soluble)
tropomyosin alpha 3 chain

%
No. of
Mowse sequence peptide
Accession no. Score coverage match
gi|6680748
88
19
10
gi|32172431
124
19
18
gi|12963491
86
25
10
gi|6753912
82
37
7
gi|37589957
61
15
7
gi|111212
95
31
12

MrW
59.8
98.1
47.4
21.2
36.7
29.2

pI
9.22
7.61
6.37
5.53
6.16
4.75

Proteins were trypsinized and analyzed by Mass Spectrometry in order to ascertain
their identities. Proteins with a Mowse score ≥ 61 were considered to be identified at
a statistically significant level. Shaded cells, less abundant proteins in old vs. young
OB; MrW, molecular weight; pI, isoelectric pH.
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Table 2.6. Comparison of results of real time RT-PCR and proteomics in OB.

Young

Old

CT

CT

Dnm1

20.5±0.3

20.9±0.4

7.26E-02

NSD

1.7

Mdh1

21.9±0.4

21.7±0.4

3.17E-01

NSD

1.9

Eno1

20.8±0.5

21.0±0.5

3.38E-01

NSD

?
2.3

Fth1

21.1±0.3

20.7±0.4

2.65E-02

1.1

2.4
?

Atp5a1

20.7±0.4

21.0±0.5

7.42E-02

NSD

1.9

Gene name

p -value

FC (RNA)

FC (Protein)

Old vs Young

Old vs Young

cDNA from OBs of 3 old mice vs. 3 young mice were analyzed (3 technical replicates per
mouse); CT, cycle threshold; is expressed as mean ± standard deviation; bold indicates p < 0.05
and concordance in the directions of fold change of the protein and mRNA; NSD, no significant
difference.
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Discussion
Studies from our laboratory have led to the successful identification of brain proteins
using a strategy based on 2D separation of proteins in models of brain aging (Poon et al. 2004b)
and in Alzheimer’s disease (Butterfield 2004; Butterfield and Boyd-Kimball 2004; Butterfield et
al. 2003; Castegna et al. 2002a; Castegna et al. 2002b; Castegna et al. 2003) and models thereof
(Boyd-Kimball et al. 2005a; Boyd-Kimball et al. 2005b), Parkinson’s disease (Poon et al.
2005a), ALS (Perluigi et al. 2005), and HIV dementia (Pocernich et al. 2005). In the current
study, 9 proteins in the OE and 20 proteins in the OB were differentially expressed in young and
old mice. The number of differentially expressed proteins is in concordance with a previous
study on aging brain using 2D gel electrophoresis in which Chen et al. determined that 5 proteins
were differentially expressed in aging human brain (Chen et al. 2003). Some proteins, including
those with a high isoelectric point and low abundance, may pose a challenge in the use of 2D
gels as a protein separation strategy (Butterfield et al. 2003).
We report in this study that proteomic changes occur in the aging murine OE and OB and
have identified the proteins that were regulated at the transcriptional level. Upon examination of
the proteomic data, we observed that the proteins that were differentially expressed in the aging
OE and OB fell into three broadly-defined functional groups, with some placed in more than one
of these groups: namely, metabolism (primarily mitochondrial metabolism); transport/motility;
and stress response (Figure 2.10). Interestingly, these processes are known to be affected in
aging (Ames et al. 1993; Poon et al. 2004a; Toescu et al. 2004; Zecca et al. 2004).
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Figure 2.10. Venn diagram showing the functional relationships of the proteins which were
expressed at significantly different levels in the aging murine OE and OB.
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Metabolism
Of the proteins involved in metabolism, ACO2, ALDH2, ATP5A1 and MDH1 are
mitochondrial enzymes, while ALDO1 and ENO1 are cytosolic. ACO2, a mitochondrial matrix
enzyme involved in the Kreb’s cycle, was found to be up-regulated in the OE of old mice as
compared to the young mice. ACO2 is a known selective target of oxidation during
aging/oxidative stress (Sastre et al. 2003) and is also known to be specifically inhibited by
peroxynitrite, leading to mitochondrial dysfunction (Radi et al. 2002a). The up-regulation of
ACO2 seen here in the OE of old mice may be a result of an accumulation of inactive enzyme
that may be either oxidized, nitrated or both, resulting in the impairment of mitochondrial
respiration. Transcriptional up-regulation of Aco2 with aging may be a cellular response to
oxidative stress for compensation for this lack of active enzyme.
ALDH2, also a mitochondrial enzyme, was down-regulated in the OE of old mice. This
enzyme is a known target for oxidation under conditions of oxidative stress (Reverter-Branchat
et al. 2004) and is thought to be protective against oxidative stress (Ohsawa et al. 2003). Also,
this enzyme has been associated with age-associated neurodegenerative diseases such as AD.
The levels of ALDH2 were found to be higher in the cerebral cortex of AD patients (Picklo et al.
2001), and its deficiency has been associated with an increased risk of AD and elevated oxidative
stress (Ohta et al. 2004); (Kim et al. 2004). We found the protein levels of this enzyme to be
down-regulated in the OE of old mice as compared to the young mice. This may result in an
increased susceptibility to oxidative stress in the OE of old mice.
ATP5A1, another mitochondrial protein and a key metabolic/bioenergetic component of
the cell, was observed to be in greater abundance in the OB of old mice as compared to young.
ATP5A1 is responsible for proton transport and oxidative phosphorylation as part of the
mitochondrial electron transport chain as a component of the ATP synthase complex. In a
microarray study, Atp5a1 was shown to be down-regulated in aging human brains (Lu et al.
2004). The protein accumulates as a fluorophore in lipofuscin granules in the brains of aging rats
(Szweda et al. 2003), the cerebral cortex of aging rats (Nicoletti et al. 1998), and the cytosol of
degenerating neurons in AD brains (Sergeant et al. 2003). Thus, it is possible that in the mouse
OB, accumulation of ATP5A1 (possibly cytosolic) with aging could lead to a decrease in
available active mitochondrial ATP5A1, and, consequentially, a decline in mitochondrial ATP
production.
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Another mitochondrial metabolic enzyme that was up-regulated in the OB of old mice
was MDH1. This protein has been shown to be expressed in the olfactory cortex (Sandberg et al.
1984). The enzyme is located within the mitochondrial matrix and is involved in the malateaspartate shuttle, which is the connecting link between glycolysis and mitochondrial respiration.
This protein transfers NADH across the mitochondrial membrane to respiratory complex I. The
up-regulation of MDH1 in the aging OB may be compensatory for reduced activity of ATP
synthase downstream in the electron transport chain.
ALDO1 is a brain-specific glycolytic enzyme that we have shown to be up-regulated in
the OE of old mice. The gene Aldo1 is highly expressed in the olfactory mucosa (Genter et al.
2003); (Tietjen et al. 2003) as determined by microarray analysis. Evidence suggests that protein
levels of glycolytic enzymes, including ALDO1, may be up-regulated during aging in order to
compensate for the metabolic decline of mitochondrial respiration (Kopsidas et al. 2000).
ALDO1 is also a target of oxidation under oxidative stress conditions (Reverter-Branchat et al.
2004) and has been shown to have reduced activity with aging in the rat lens (Bours et al. 1988).
ENO1, a key glycolytic enzyme and also known as α-enolase (a subunit of brain-specific
enolase; (Keller et al. 1994), was up-regulated in the OB of old mice. Our transcriptional
analysis implies that ENO1 was post-transcriptionally regulated, which may indicate reduced
proteasomal degradation of this protein as a result of ENO1 possibly being oxidized/nitrated or
due to decreased activity of the proteasome during aging (Keller et al. 2004). ENO1 is also
known to be up-regulated at the protein level in AD brains (Schonberger et al. 2001). Under
conditions of oxidative stress, ENO1 is a specific target of oxidation and is both oxidized and
nitrated in brains of AD patients (Reverter-Branchat et al. 2004); (Castegna et al. 2002b)
(Castegna et al. 2003). Interestingly, similar to ALDO1, an up-regulation of this enzyme may be
part of a glycolytic compensation for mitochondrial metabolic decline in the OB.
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Transport/Motility and Stress response
While recognizing the overlapping transport and/or stress-associated roles of some of the
metabolic enzymes described above, we have grouped the remaining proteins into these two
categories based on what appears to be their primary function.
FTH1, which we showed to be highly up-regulated in the OB of old mice, is a transport protein
primarily involved in iron homeostasis. We also confirmed this result immunochemically and
demonstrated that Fth1 is up-regulated at the transcriptional level as well. The gene for Fth1 was
reported to be expressed in the olfactory sensory nerves (Tietjen et al. 2003), and the protein has
been localized in oligodendrocytes and astrocytes of various human brain regions (Connor et al.
1990). Brains of Fth-/- mice show characteristics of increased oxidative stress (Thompson et al.
2003). Interestingly, both Fth1 and Aco2 mRNAs contain iron-responsive elements (IREs), and
their translation to protein is regulated by iron levels through the mediation of iron binding
proteins (Schalinske et al. 1998). Iron (II) promotes lipid and protein oxidation in oxidative stress
conditions, and the levels of this metal ion have been shown to increase in aging and
neurodegenerative diseases, with high accumulation in lipofuscin granules (Terman and Brunk
2004); (Killilea et al. 2004). Thus, FTH1 may be up-regulated in response to elevated oxidative
stress and may be exerting a protective effect in the aging olfactory system by sequestering the
increased levels of iron ions.
PPIA, also known as cyclophilin A, is an abundant protein of the immunophilin family
that is the primary target for the immunosuppressant cyclosporin A in humans (Jin et al. 2004).
Cyclosporin A is a neuroprotector under conditions of ischemic injury and acts via modulation of
the mitochondrial permeability transition pore dynamics and maintenance of mitochondrial
homeostasis (Crompton 2004; Sullivan et al. 1999). PPIA is a pro-inflammatory molecule that is
secreted by macrophages (Jin et al. 2004), among other cells, in response to oxidative stress. The
known functions of this protein include the activation of NF-κB-mediated inflammatory response
in endothelial cells (Jin et al. 2004) and chaperone activity under stress in vitro (Ou et al. 2001).
Ppia is expressed in olfactory sensory neurons as shown by single-cell microarray studies
(Tietjen et al. 2003). In the OE of old mice, we showed an up-regulation of PPIA protein levels
that we confirmed by immunochemical analysis. An up-regulation of PPIA suggests a response
to increased oxidative stress in the aging OE which would aid in protection via its chaperone
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activity and/or may be functioning in an anti-apoptotic manner. ENO1, which was described
above under metabolism, also has chaperone activity (Pancholi 2001).
TPM3, another protein that was up-regulated in old OB, is an actin-binding protein.
TPM3 undergoes iron (II)-mediated oxidation under oxidative stress that targets this protein for
proteasomal degradation (Drake et al. 2002). Altered levels of TPM3 may affect
anterograde/retrograde transport in the olfactory neurons and/or mitochondrial movement
leading to nerve ending loss in aging mice.
DNM1, a protein involved in cellular motor activity and receptor-mediated endocytosis,
has been localized in the olfactory system. The protein is co-localized with clathrin in cell
bodies, dendrites and dendritic knobs of olfactory receptor neurons (Rankin et al. 1999). DNM1
has been shown to be expressed in rat OB where it forms a stable complex with synaptojanin-1
and endophilin3 (ENDO3), an inhibitor of clathrin-mediated endocytosis that co-localizes with
dopamine D2R receptors at the synaptic termini of olfactory sensory neurons (Sugiura et al.
2004); (Faire et al. 1992). At the transcriptional level, Dnm1l was observed to be down-regulated
in the aging human brain (Lu et al. 2004). Here, we have shown that DNM1 protein is downregulated in the OB of old mice, suggesting altered neurotransmitter reuptake by olfactory
neuronal synapses with aging.
Our results are the first demonstration of proteomic changes occurring in the normally
aging olfactory system. These alterations in the protein profile of the aging olfactory epithelium
and olfactory bulb are specific to the pathways involving mitochondrial and cytosolic
metabolism, intracellular transport and altered response to stress. Our transcriptional analysis
begins to identify the mechanisms of regulation of these proteins in the aging olfactory system.
Our results on differences in the proteins and associated mRNAs in the OE and OB of old and
young mice may provide insight into changes in the olfactory system in aging and in age-related
neurodegenerative disorders.
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Introduction
Olfactory sensory decline is associated with aging and age-related neurodegenerative
disorders including Alzheimer’s and Parkinson’s diseases (Doty 1991a; Murphy et al. 2002), yet
researchers are only beginning to understand the basic molecular and cellular mechanisms
underlying age-associated olfactory dysfunction. In addition to the many neuroanatomical and
immunohistochemical changes that have been documented in the olfactory epithelium (OE) and
olfactory bulbs (OBs) of aging humans (Kovacs 2004), several studies have suggested that
increased oxidative stress occurs in the olfactory system of elderly humans. Results from our
laboratory demonstrated age-related reductions in the levels of glutathione-related and
antioxidant enzymes in the OE (Krishna et al. 1995) and in HSP70 expression in human
olfactory sensory neurons (Getchell et al. 1995). In the OBs of elderly humans, high levels of
lipofuscin, a pigment that represents the intralysosomal accumulation of undegradable
oxidatively modified molecules (Terman and Brunk, 2006), as well as numerous microglia,
which generate free radicals, were observed (Getchell 2002); Getchell et al., 2001).
Additionally, in senescence-accelerated mice, an animal model of aging, oxidative stressassociated gene expression was up-regulated in the OE (Getchell et al. 2004; Getchell et al.
2003d).
Oxidative stress is a major mediator of the progressive decline in cellular function during
aging in various tissues. In the aging brain, free radical-mediated oxidative stress results in the
oxidation of proteins, nucleic acids, and lipids, altering the structure and function of these
macromolecules (Beckman and Ames 1998). Increased protein oxidation has been associated
with reduced enzyme activity leading to cellular dysfunction in aging as well as in age-related
neurodegenerative diseases (Butterfield and Stadtman 1997; Dalle-Donne et al. 2006)a).
Interestingly, not all proteins are oxidized, and many enzymes preserve their activity during
aging, suggesting that specific proteins are targets of oxidative modification during aging and in
age-related neurodegenerative disorders (Butterfield et al. 2003).
In a previous proteomics study, we investigated the steady state levels of proteins in the OBs of
1.5- and 20-month old mice and reported that 20 proteins were expressed at significantly
different levels at the 2 ages (Poon et al. 2005b). Six of these proteins were identified and were
associated with functions related to oxidative stress, metabolism including mitochondrial
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metabolism, and transport. One, ferritin heavy chain (FTH), was differentially regulated at the
transcriptional level as well. Several of these proteins have been previously identified as specific
targets of oxidation in aging and/or oxidative stress in other systems (Radi et al. 2002b; Sastre et
al. 2003).
The aim of the current study was to determine if elevated oxidative stress as indicated by
the level of protein oxidation occurs in the murine OB. I investigated two forms of protein
oxidation:

carbonylation and nitration.

I used redox proteomics to evaluate protein

carbonylation, measuring total levels of protein oxidation and identifying several oxidized
proteins, and immunohistochemistry to evaluate protein nitration and its cellular localization.
Our results demonstrate that: 1) both total protein carbonylation and nitration are elevated in the
OBs as a function of age; 2) specific proteins that we have identified are targets of carbonylation;
3) localization of 2 targets of protein oxidation are localized in neuronal and glial cell types that
perform key roles in olfactory sensory processing and cellular homeostasis; and 4) protein
nitration targets primarily the vasculature of the OB. These results provide the first proteomics
study that demonstrates molecular targets of and mechanisms by which protein oxidation could
impact olfactory function during aging.
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Materials and methods

Animals
A total of eighteen C57BL/6 male mice, obtained from Harlan, USA were used for this
study; eight, from the National Institute on Aging Aged Rodent Colonies, were 20 months old,
three were 6 months old, and seven were 1.5 months old. At 1.5 months of age, mice are
sexually mature, so “young adult” could also be used to describe these mice. The mice were
maintained in an animal facility at the University of Kentucky Department of Laboratory Animal
Research on a 12 hr light:dark cycle in Bioclean units with sterile-filtered air and provided food
and water ad libitum. All protocols were implemented in accordance with NIH guidelines and
approved by the University of Kentucky Institutional Animal Care and Use Committee. The
body weights of the 1.5 month-old mice ranged from 19 to 24 g, those of the 6-month old mice
from 25 to 32 g, and those of the 20-month old mice from 32 to 35 g. For protein analysis,
following euthanasia with CO2, the OBs from four 1.5-month old and five 20-month old mice
were removed quickly, weighed and snap frozen in liquid N2. For histology, three 1.5-month
old, three 6-month old, and three 20-month old mice were perfused with 3% paraformaldehyde
followed by tissue processing and sectioning (coronal) as previously described (Kwong et al.
2004).

Sample Preparation
The OB samples were homogenized in a lysis buffer (10 mM HEPES, 137 mM NaCl, 4.6
mM KCl, 1.1 mM KH2PO4, 0.6 mM MgSO4) containing the protease inhibitors leupeptin (0.5
mg/mL), pepstatin (0.7 µg/mL), trypsin inhibitor (0.5 µg/mL), and PMSF (40 µg/mL).
Homogenates were centrifuged at 15,800 g for 10 min to remove debris. The supernatant was
extracted to determine the total protein concentration by the BCA method (Pierce, Rockford, IL).

Immunochemical Detection of Total Protein Carbonyl Levels
Slot blots were used to detect the level of total protein carbonylation in the OBs of young
and old mice as previously described (Poon et al. 2005b).

Briefly, protein carbonyls in

homogenates from the OBs of the four young and five old mice were derivatized by 10 mM 2,4dinitrophenylhydrazine (DNPH) to form the hydrazone (DNP). To determine carbonyl levels,
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250 ng of DNP-protein adducts were loaded into each slot.

The technique for the

immunochemical detection of the DNP-protein adducts was described previously (Poon et al.
2005b).

Two-dimensional gel electrophoresis
Tissue homogenates containing 200 μg of protein from the OBs of 4 1.5-month old and 5
20-month old mice were each applied to nine pH 3-10 ReadyStrip™ IPG strips (Bio-Rad,
Hercules, CA) for isoelectric focusing (IEF). After focusing, the IEF strips were stored at –80oC
until second dimension electrophoresis was performed. For second dimension electrophoresis,
nine Linear Gradient (8-16%) Precast criterion Tris-HCl gels (Bio-Rad) were used to separate
proteins according to their molecular weight (MrW) after IEF. Precision ProteinTM Standards
(Bio-Rad) were run along with the samples. After electrophoresis, the 9 separate gels were
incubated in fixing solution for 20 min. The gels were stained with SYPRO Ruby for 2 hr, after
which the gels were placed in deionized water overnight for destaining.

Western Blotting
Western blotting of the 2D gels was performed as previously described (Poon et al.
2005b). Two hundred μg of protein from each of the four 1.5-month old and five 20-month old
mice were incubated with 10 mM DNPH solution (in 2N HCl) at room temperature for 20 min.
The gels were prepared in the same manner as for 2D electrophoresis as described above. The
proteins from the 2D electrophoresis gels were transferred onto nitrocellulose paper using a
Transblot-Blot® SD semi-Dry Transfer Cell (Bio-Rad) at 15V for 2 hr. The DNP adducts of the
carbonyls of the OB proteins were detected immunochemically as described above.

Image Analysis and Statistics
The gels and nitrocellulose blots were scanned and saved in TIF format using a Storm
860 Scanner (Molecular Dynamics) and a Scanjet 3300C (Hewlett Packard), respectively.
PDQuest software (Bio-Rad) was used for matching and analysis of visualized protein spots
among the different gels and oxyblots. The principles of measuring intensity values by 2D
analysis software are similar to those of densitometric measurement. The average mode of
background subtraction was used to normalize intensity values, which represent the amount of

47

protein (total protein on gel or oxidized protein on oxyblot) per spot. After completion of spot
matching, data analysis was performed as follows: to compare the relative amounts of each
matched protein in the 4 individual SYPRO Ruby stained gels from 1.5-month old mice and the
5 individual SYPRO Ruby stained gels from the 20-month old mice, Student’s t-tests were
performed on the average normalized intensity for each spot.

Similarly, to compare the

differences in protein-bound carbonyls for each matched spot, Student’s t-tests were performed
on the average normalized intensity from the 4 individual oxyblots from the 1.5-month old mice
and the 5 individual oxyblots from the 20-month old mice. The degree of carbonylation, a
measure of specific protein oxidation, was determined for each matched spot in each age group
by dividing the intensity of the protein carbonyl spot on the oxyblots by the intensity of the
protein spot on the SYPRO Ruby stained gel. To compare the degree of carbonylation for each
matched spot, Student’s t-tests were performed on these ratios. Similar statistical analyses are
routinely used for proteomics data analysis (Korolainen et al., 2002; Maurer et al., 2005, Huang
and Li, 2006; Poon et al., 2006a)(Boyd-Kimball et al. 2006; Korolainen et al. 2002; Maurer et al.
2005). Three spots that had statistically different degrees of carbonylation (p-values < 0.05) and
one spot that showed a significant difference in protein-bound carbonyls and a trend toward a
significant difference in the degree of carbonylation (p = 0.06) in the OBs of 20- vs. 1.5-month
old mice were selected for identification by MS.

Trypsin digestion
Samples were digested using the techniques previously described (Poon et al. 2005b).
Briefly, the selected protein spots, chosen by PDQuest imaging software (Bio-Rad) as being
different between young and old mice, were excised and washed with ammonium bicarbonate
(NH4HCO3), followed by acetonitrile at room temperature. The protein spots were incubated
with dithiothreitol, and then iodoacetamide solutions. The gel pieces were digested with 20 ng/µl
modified trypsin (Promega, Madison, WI) using 25 mM NH4HCO3 with the minimum volume to
cover the gel pieces. The gel pieces were chopped into smaller pieces and incubated at 37°C
overnight in a shaking incubator.

48

Mass Spectrometry (MS) and Protein Identification
Digests (1 μL) were mixed with 1 μL α-cyano-4-hydroxy-trans-cinnamic acid (10
mg/mL in 0.1% TFA:ACN, 1:1, v/v). The mixture (1 μL) was deposited onto a fast evaporation
nitrocellulose matrix surface, washed twice with 2 μL 5% formic acid, and analyzed with a
TofSpec 2E (Micromass, Manchester, UK) MALDI-TOF mass spectrometer in reflectron mode.
The mass axis was adjusted with trypsin autohydrolysis peaks (m/z 2239.14, 2211.10, or 842.51)
as lock masses. The MALDI spectra used for protein identification from tryptic fragments had a
signal/noise ratio above 10 and were selected by MassLynx software (Waters Corp., Milford,
MA); the resulting peak lists were checked manually to ensure that the peaks were present in the
spectrum.

Only the selected peaks were submitted to the MASCOT search engine

(http://www.matrixscience.com), which searched for matches in the NCBI protein databases.
Peptide mass fingerprinting used the assumption that peptides are monoisotopic, oxidized at
methionine residues and carbamidomethylated at cysteine residues. Up to 1 missed trypsin
cleavage was allowed.

Mass tolerance of 100 ppm was the window of error allowed for

matching the peptide mass values. Proteins were identified based on database-matching, with a
MOWSE score of > 62 considered as significant, as well as on the correspondence between the
expected and experimental isoelectric points (pIs) and molecular weights (MWs).

Histology and immunohistochemistry
To visualize the histological organization of the OB, defatted, rehydrated frozen sections
were stained with 1% aqueous cresyl violet (Sigma) solution. To evaluate the amount of
autofluorescent lipofuscin, sections were rehydrated in PBS, coverslipped, and examined through
the FITC filter. For immunohistochemistry, standard indirect immunofluorescence techniques
were used as previously described (Kwong et al. 2004) to localize 2 proteins that were identified
by proteomics (ALDO1 and FTH), to identify specific cell types, to evaluate co-localization
[glial fibrillary acidic protein (GFAP) for astrocytes; CD68 and F4/80 for microglia], and to
evaluate and localize sites of nitration [3-nitrotyrosine (3-NT) immunoreactivity]. Sections were
incubated with primary antibodies overnight at 4°C; all secondary antibodies were from Jackson
ImmunoResearch Laboratories (West Grove, PA). For aldolase 1 (ALDO1), a goat polyclonal
antibody (Santa Cruz Biotechnology, Santa Cruz, CA) was used at a 1:50 dilution; the secondary
antibody was FITC-conjugated anti-goat IgG used at a dilution of 1:100. Rabbit anti-ferritin
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heavy chain (FTH) polyclonal antibody (Alpha Diagnostics, San Antonio, TX) was used at a
dilution of 1:100; FITC-conjugated anti-rabbit IgG was used at 1:100 for immunological
detection. Mouse polyclonal anti-GFAP (Chemicon Intl., Temecula, CA) was diluted to 1:2500;
immunoreactivity was visualized with rhodamine red X-conjugated anti-mouse IgG at a dilution
of 1:200.

Rat anti-rat monoclonal anti-CD68 (Serotec, Raleigh, NC) and F4/80 (Caltag

Laboratories/Invitrogen, Carlsbad, CA) were diluted to 1:50; immunoreactivity was visualized
with rhodamine red X-conjugated anti-rat IgG at a dilution of 1:200. Rabbit polyclonal anti-3NT (Upstate Cell Signaling Technology, Inc., Danvers, MA) was used at a 1:100 dilution;
immunoreactivity was visualized using FITC-conjugated anti-rabbit IgG at 1:100. Coverslips
were mounted with Vectashield mounting medium with DAPI to visualize nuclei (Vector
Laboratories, Burlingame, CA).
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Results

Measurement of total protein carbonylation and identification of differentially carbonylated
proteins
To determine whether there was an increase in protein oxidation in the OBs of 20-month
vs. 1.5-month old mice, protein-bound carbonyls were derivatized with DNPH and relative
protein carbonylation was then measured immunochemically using the slot blot technique. Total
protein carbonylation was significantly elevated by 17% in OBs of 20-month vs. 1.5-month old
mice (Figure 3.1). We utilized a two-dimensional (2D) gel electrophoresis/MS-based redox
proteomics approach (Dalle-Donne 2006) to identify proteins differentially oxidized in the OBs
of 20- vs. 1.5-month old mice (flowchart, Figure 3.2). Briefly, 2D gels and oxyblots were
prepared as described above, and carbonylated protein spots were evaluated densitometrically for
the 4 1.5-month and 5 20-month old individual mice. PDQuest software analysis identified a
total of 431 protein spots on the SYPRO Ruby red-stained 2D gels and 360 oxidized proteins on
the 2D oxyblots and matched 164 spots on the oxyblots to corresponding spots on SYPRO Ruby
red stained gels. Representative 2D gels and oxyblots of OBs from 1.5- and 20-month old mice
are shown in Figure 3.3. The degree of carbonylation (intensity of spot on oxyblot/intensity of
spot on protein gel) increased for 104 proteins, decreased for 49 proteins, and was unchanged for
11 proteins in the OBs of 20-month vs. 1.5-month old mice. Three spots, numbers 306, 4606 and
5607, exhibited significantly different degrees of oxidation in the OBs of 20- vs. 1.5-month old
mice, and one spot, number 3202, showed a significant difference in protein-bound carbonyls
and a trend toward a significant difference (p = 0.06) in the degree of oxidation (Figure 3.4).
These 4 spots, whose localization on a representative SYPRO ruby-stained 2D gel is shown in
Figure 3.5, were selected for identification by MS and peptide mass fingerprinting. The proteins
were identified as aldolase 1 (ALDO1/ALDOA, spot 306; representative MS analysis shown in
Figure 3.6), dihydropyrimidinase-like 2 (DPYSL2/DRP2, spot 4606); and heat shock protein 9A
(HSPA9A, spot 5607; Table 3.1). For spot 3202, two possibilities were identified but with low
MOWSE scores (21 and 19) and will not be considered further. ALDO1 showed an increased
level of protein-bound carbonyls in 20- vs. 1.5-month old mice, and HSPA9A and DPYSL2
showed apparent decreases, with the corresponding degree of oxidation following a similar
pattern.
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Figure 3.1. Total protein carbonylation in olfactory bulbs (OBs) from 1.5- and 20-month old
mice. Histogram shows a significant increase (17%) in total protein carbonylation in OBs of 20vs. 1.5-month old mice as determined by densitometric analysis of slot blots. AU, arbitrary
densitometric units. *, p < 0.05; error bars, standard error.
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Figure 3.2. Flowchart summarizing experimental design and results of redox proteomics. See
text for details. 2D, 2-dimensional; DNPH, 2,4-dinitrophenylhydrazine; MS, mass spectrometry.
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Figure 3.3. Representative two-dimensional gels and corresponding oxyblots of olfactory bulb
(OB) proteins from 1.5- and 20-month old mice. Left, SYPRO Ruby-stained 2-dimensional (2D)
gels for total protein from the OBs of a 1.5-month old mouse (top) and a 20-month old mouse
(bottom). Right, oxyblots to detect protein carbonylation in proteins from OBs of the same mice.
DNPH, 2,4-dinitrophenylhydrazine.
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Figure 3.4. Relative carbonylation levels of specific protein spots in OBs of 1.5- and 20-month
old mice. Histograms show the relative amount of protein in arbitrary densitometric units (y
axis) from SYPRO Ruby-stained 2D gels (left column), the relative amount of protein-bound
carbonyls in arbitrary densitometric units (y axis) in the matched spot on the 2D oxyblots (center
column), and the degree of oxidation (ratio of amount of protein-bound carbonyls to amount of
protein, right column). *, p < 0.05; error bars, standard error.
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Figure 3.5. Representative two-dimensional gel of total protein from olfactory bulb (OB) of a
1.5-month old mouse stained with SYPRO Ruby. The circled spots correspond to the proteins
selected for identification based on their differential oxidation in the oxyblots.

56

Figure 3.6. Representative mass spectrometric identification of aldolase 1 (ALDO1). (Top)
MALDI mass spectrum for spot # 306 is shown. (Bottom) MASCOT-based peptide mass
fingerprinting identified protein as ALDO1.
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Table 3.1. Differentially oxidized proteins identified by proteomic analysis
Spot #

Protein

306

aldolase 1

4606
5607

dihydropyrimidinaselike 2
heat shock protein 9A

Protein

MOWSE

Symbol

Score

ALDO1

102

34%

73.8

8.55

DPYSL2

42*

13%

62.6

5.95

HSPA9A

59*

16%

73.8

5.91

Coverage

MW
(kDa)

pI

Shaded cells, increased specific protein carbonylation in OBs of 20- vs. 1.5-month old mice;
unshaded cells, decreased specific carbonylation. *, MOWSE score < 62 is not significant,
but MW and pI correspond to protein spot.
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Protein carbonylation status of previously identified proteins
Using proteomics, we previously reported the significant up- or down-regulation of
steady state levels of 20 proteins in the OBs of 20-month vs. 1.5-month old mice (Poon et al.
2005b). To determine if any of these proteins or others identified in this study were oxidized, I
determined the levels of protein-bound carbonyls for each. This was done by matching the
SYPRO-stained 2D-gel spots for these previously identified proteins to corresponding spots on
the newly-generated oxyblots. The results are summarized in Table 3.2. Among 15 proteins
whose steady-state levels were previously shown to be up-regulated, 9 proteins were
carbonylated, although the degree of carbonylation in 20-month vs. 1.5-month old mice was not
significantly different for any of them. Carbonylated proteins whose steady-state levels were upregulated included 2 identified in our previous study, ATP synthase isoform 1 (ATP5A1) and
ferritin heavy chain (FTH), and 1 newly-identified protein, calpain 12 (CAPN12, spot 4204), as
were unidentified spots 1501 and 6106. Proteins whose steady-state levels were previously
shown to be down-regulated included 1 identified in the previous study, dynamin-1 (DNM1),
and 2 newly-identified proteins , G protein coupled receptor 135 (GPR135, spot number 504)
and spermatogenesis-associated protein 2 (SPATA, spot number 2704). In addition, 3 proteins
whose steady-state levels were not significantly different in 1.5-month vs. 20-month old mice but
were carbonylated were identified as multimerin 1 (MMRN1, spot number 5101), valosincontaining protein (VCP, spot number 6704), and retinaldehyde binding protein 1 (RLBP1, spot
number 6805). CALPN12 and RLBP1 were carbonylated on oxyblots from 20-month old mice
only, while the remainder were carbonylated on oxyblots from both 1.5-month and 20-month old
mice. In addition, 5 proteins whose steady-state levels were significantly up-regulated in 20- vs.
1.5-month old mice were not detectably carbonylated; they were RAS-related protein RAB14
(RAB14), heat shock 70 kDa protein 8 (HSPA8), enolase 1 (ENO1), malate dehydrogenase
(MDH1), and tropomyosin α3 chain (TPM3).
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Table 3.2. Carbonylation status of proteins with previously determined relative steady-state
levels in OBs of old vs. young mice
Spot
#

Protein

Symbol

MOWSE
score

Coverage
(%)

FC
(steadystate
level)

MW
(kDa)

pI

Carbonylated proteins
G protein coupled
504
GPR135
45*
8
50.2
10
↓2.3
receptor 135**
ATP synthase
604
ATP5A1
88
19
59.8
9.2
↑1.9
isoform 1
spermatogenesis2704 associated protein SPATA2
44*
9
58.7
8.9
↓2.6
2**
3802
dynamin 1
DNM1
124
19
98.1
7.6
↓1.8
4204
calpain 12**
CAPN12
46*
16
52
6.1
↑1.6
5101
multimerin 1**
MMRN1
65
14
NSD
137.1 7.7
ferritin heavy
5104
FTH
82
37
21.2
5.5
↑1.9
chain
valosin6704
containing
VCP
206
33
NSD
89.9 5.1
protein**
retinaldehyde
6805
binding protein
RLBP1
142
48
NSD
36.7
5.0
1**
Proteins not detectably carbonylated
RAS-related
110
RAB14
63
33
24.1
5.9
↑7.0
protein RAB14
heat shock 70
1304
HSPA8
199
48
71.1
5.4
↑2.3
kDa protein 8
4503
enolase 1
ENO1
85
25
47.7
6.4
↑2.4
malate
5302 dehydrogenase 1,
MDH1
61*
15
36.7
6.2
↑1.5
NAD (soluble)
tropomyosin α3
7206
TPM3
95
31
29.2
4.8
↑1.9
chain
FC, fold change in steady-state protein level in the OB of 20- vs. 1.5-month old mice (Poon
and Vaishnav et al., 2005); NSD, no significant difference in steady-state protein level.
*, MOWSE score < 62 is not significant, but MW and pI of spot correspond to
corresponding protein; **, proteins newly identified from Poon and Vaishnav et al. 2005a.
Shaded cells, carbonylated proteins observed in oxyblots from 20-month old mice only;
other carbonylated proteins observed in oxyblots from both 1.5- and 20-month old mice.
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Protein nitration
To determine whether elevated oxidative stress resulted also in protein nitration in the
OB, we investigated the presence, relative intensity, and localization of immunoreactivity for
protein-bound 3-NT in the OBs of 1.5-month, 6-month, and 20-month old mice (Figure 3.7). In
1.5-month old mice (Figure 3.7A), faint and diffuse 3-NT immunoreactivity occurred primarily
in the external plexiform layer with localization in an occasional blood vessel. In 6-month old
mice (Figure 3.7B), immunostaining for 3-NT increased, with stronger staining in blood vessels
as well as staining around the rims of lipofuscin (gold/orange)-containing microglia.

The

strongest and most abundant staining was observed in 20-month old mice (Figure 3.7C);
numerous blood vessels and microglia (identified by staining adjacent sections for CD68, not
shown) in all layers of the OB were intensely immunoreactive for 3-NT.

Immunohistochemical localization of ALDO1 and FTH
Because ALDO1, a key glycolytic enzyme, showed a significant elevation in its degree of
carbonylation in OBs of 20- vs. 1.5-month old mice, we determined its cellular localization using
immunohistochemistry (Figure 3.8) to identify the cell type(s) that might be affected by the
potential impairment of its function. Immunoreactivity for ALDO1 was localized in stellate cells
(Figure 3.8A) primarily in the granule cell layer of the OB in 1.5-month old mice. A similar
intensity and distribution of staining was observed in 20-month old mice (not shown),
suggesting, as did our previous proteomics analysis, that there were no apparent differences in its
steady-state level at these ages. To identify the cell type(s) expressing ALDO1, we doublestained for ALDO1 (Figure 3.8A) and GFAP (Figure 3.8B), an astrocytic marker. ALDO1 was
co-localized with GFAP in numerous astrocytes (Figure 3.8C) in the granule cell layer. ALDO1
did not colocalize with CD68 or with F4/80, microglial markers, both of which stained cells
restricted to the glomerular layer (not shown). This confirmed the astrocyte-specific expression
of ALDO1 primarily in the granule cell layer of the OB.
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Figure 3.7. Localization of 3-nitrotyrosine (3-NT) immunoreactivity in the olfactory bulbs
(OBs) of 1.5-, 6-, and 20-month old mice. (A) In 1.5-month old mice, very faint 3-NT
immunoreactivity is localized in an occasional blood vessel (arrow). (B) In 6-month old mice,
immunoreactivity in blood vessels is stronger (arrow), and immunoreactive microglia are also
observed.

(C)

In 20-month old mice, intense immunofluorescence for 3-NT (arrows) is

localized in blood vessels as well as in microglia throughout the OB. Sections are counterstained
with DAPI (blue, nuclear stain) to show the laminar organization of the OB. GL, glomerular
layer; EPL, external plexiform layer; MCL, mitral/tufted cell layer; IPL, internal plexiform layer;
GCL, granule cell layer. Calibration bar, 50μm.
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Figure 3.8. Localization of aldolase 1 (ALDO1) immunoreactivity in astrocytes of the olfactory
bulb (OB). (A) Immunoreactivity for ALDO1 (green) occurs primarily in stellate cells of the
granule cell layer.

(B)

Identification of astrocytes in the same region is shown by

immunofluorescence for glial fibrillary acidic protein (GFAP, red). (C) ALDO1 and GFAP are
co-localized (yellow) in numerous astrocytes. Arrows, representative cell showing positive
immunoreactivity for both antigens. Calibration bar, 25 μm.
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Because of its known involvement in aging and oxidative stress in the brain and its
increased level of expression as well as its carbonylation in the OB of 20-month old mice, we
also selected the iron-management protein FTH for cellular localization (Figure 3.9). FTH was
localized in a punctate pattern primarily in mitral/tufted cells in 1.5-, 6-, and 20-month old mice
(Figs. 3.9A, D, and G, respectively), as can be seen by comparison with adjacent cresyl violetstained sections (Figure 3.9B, E, and H). Qualitatively, mitral/tufted cells contained the least
immunoreactivity for FTH in the 1.5-month old mice, an intermediate level in the 6-month old
mice, and the greatest in the 20-month old mice, indicating higher levels of the protein per cell in
the oldest mice, confirming our previous results on its steady-state levels.

Less abundant

punctate staining was also observed in periglomerular cells (not shown), with the intensity
appearing to increase slightly with age. Also evident were autofluorescent (gold) lipofuscin
granules, which were almost undetectable in the mitral cell layer in the 1.5-month old mice
(Figure 3.9C), present in the 6-month old mice (Figure 3.9F), and most abundant in the 20-month
old mice (Figure 3.9I). Large amounts of lipofuscin were also observed in the glomerular and
granule cell layers of the OB (not shown), with its abundance increasing with age as shown in
the mitral/tufted cell layer.
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Figure 3.9. Ferritin heavy chain (FTH) immunolocalization and lipofuscin autofluorescence in
mitral/tufted cell layer (MCL) of olfactory bulb (OB). Immunoreactivity for FTH (A, D, G) is
localized in mitral/tufted cells, shown by cresyl violet staining (B, E, H, arrows) of near-adjacent
sections from OBs of mice of different ages. (A) Sparse punctate FTH immunoreactivity
(arrow) is localized in mitral/tufted cells in 1.5-month old mice. (B) Somewhat more abundant
punctate FTH immunoreactivity occurs in mitral/tufted cells in 6-month old mice. (C) In 20month old mice, very intense FTH immunoreactivity (arrow) makes punctate staining appear
congruent. Autofluorescent lipofuscin (gold) in the mitral/tufted cell layer also increases in
abundance, with the least in 1.5-month old mice (C), an intermediate amount in 6-month old
mice (F), and the most in 20-month old mice (I). EPL, external plexiform layer; IPL, internal
plexiform layer. Calibration bar, 50 μm.
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In summary, I have used redox proteomics and immunohistochemistry to investigate the
age-related oxidation of proteins in the murine OBs.

I have demonstrated that both

carbonylation and nitration of OB proteins increased with increasing age.

Our results

demonstrate that there was a significant increase in total protein carbonylation in the OBs of 20vs. 1.5-month old mice, and that specific proteins were targets of carbonylation. In addition, our
results indicate that protein nitration contributed to increased protein oxidation in the OBs of 20vs. 6- vs. 1.5-month old mice. Both forms of protein oxidation occur in identified sites that may
potentially have major impacts on olfactory function with increasing age.
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Discussion
This study has applied a novel approach to olfactory neurobiology, utilizing redox
proteomics (Dalle-Donne 2006) for the measurement of relative levels of protein carbonylation
in the murine OB and the identification of proteins that are specific targets of carbonylation.
Additionally, we used immunohistochemistry for the cellular localization of the proteins targeted
for carbonylation and for the determination of the relative amounts and localization of targets of
protein nitration. This study provides the first results that identify potential mechanisms by
which oxidative stress resulting in protein oxidation could contribute to age-related olfactory
dysfunction.
The results with redox proteomics documented an increase in total protein carbonylation
indicative of oxidative stress in the OBs of 20-month compared to 1.5-month old mice. As
determined by software analysis, 164 proteins had matching spots on the SYPRO-stained gels
and the oxyblots; 63% of them showed an increase in carbonylation, 30% showed an apparent
decrease in carbonylation, and 7% were approximately equally carbonylated in both. Changes,
predominantly increases, in protein carbonyl content have been demonstrated in other regions of
the brains of old mice and rats (Choi et al. 2004; Poon et al. 2006a; Poon et al. 2004b). The
degree of oxidation for 3 of the carbonylated proteins changed significantly and that for 1
additional spot showed a trend toward a significantly different level of carbonylation. The 3
proteins with significant differences in carbonylation were identified; this number is comparable
to the numbers of proteins identified in the studies of aging brain cited above.
One of the differentially oxidized proteins was ALDO1, with a 13-fold increase in
carbonylation in 20- compared to 1.5-month old mice. This protein has been reported to be a
specific target of oxidation under conditions of oxidative stress in other tissues as well (Barreiro
et al. 2005; Koeck et al. 2004; Reverter-Branchat et al. 2004) ALDO1 associates with the
mitochondrial outer membrane (Taylor et al. 2003), bringing it into close contact with
superoxide radicals and peroxynitrite (Koeck et al. 2004) that would facilitate its oxidation.
Increased carbonylation of ALDO1 has been demonstrated to result in decreased enzyme activity
(Barreiro et al. 2005); decreases in activity with aging have been observed in rat lens (Bours et
al. 1988) and mouse liver (Gershon and Gershon 1973). ALDO1 was localized primarily in a
sub-set of astrocytes in the granule cell layer of the OB. The ALDO1-immunoreactive astrocytes
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do not clearly correspond to any one of the laminar-specific morphological subtypes of
astrocytes that have been described in the adult OB, although many resemble the semicircular
form (Chiu and Greer 1996). Astrocytes play a key role in regulating neuronal synaptic activity
via glutamate reuptake and de novo synthesis (Fields and Stevens-Graham 2002; Pellerin and
Magistretti 1994). The localization of ALDO1, a selective target of oxidative modification in the
aging OB, in astrocytes in the granule cell layer suggests that glial-neuronal homeostasis in the
OB may be impaired with aging.
The other 2 proteins identified in this study, DPYSL2 and HSPA9A, showed a significant
decrease in specific carbonyl levels in OBs of 20- vs. 1.5-month old mice. DPYSL2/DRP2 is a
member of the dihydropyrimidinase-related protein family.

These proteins are involved in

axonal outgrowth and neuronal migration. DRP2 was up-regulated in brains of old mice (Poon
et al. 2006b) and is a known target of carbonylation in the aging brain (Poon et al. 2004b) and in
Alzheimer’s disease (Castegna et al. 2002b).

HSPA9A/mortalin/mitochondrial HSP70, an

HSP70 chaperone family member localized primarily in mitochondria (Kaul et al. 2002),
performs a key role in basic biological processes such as intracellular protein trafficking, cell
cycling, and stress response.

The related chaperone HSP70 was localized in mammalian

olfactory sensory neurons (Carr et al. 1994) and was down-regulated in an age-dependent
manner (Getchell et al. 1995). HSPA9A was reported to show an increase in carbonylation in
brains of old as compared to young mice (Choi et al. 2004). An apparent decrease in protein
carbonylation as observed for these two proteins in the OB of 20- vs. 1.5-month old mice may
result from several mechanisms (Korolainen et al. 2002; Shringarpure and Davies 2000). The
oxidized proteins may become cross-linked and accumulate as aggregates, thus removing the
oxidized protein molecules from the soluble fraction that is assayed by the proteomics
technology used in our study. Aggregates of oxidized proteins result in the accumulation of
lipofuscin (Keller et al. 2004), which we observed in abundance in the OBs of the 20-month
compared to 1.5-month old mice in this study, suggesting that this mechanism may explain at
least in part the apparent reduction in oxidation levels of these proteins. Oxidized proteins may
also undergo higher rates of synthesis and/or turnover; because we examined only the steadystate level of oxidized proteins in the OB, a higher rate of turnover of the oxidized proteins may
also have resulted in apparent decreases in the concentration of the carbonylated proteins.
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In our previous study, we used proteomics to identify several proteins whose levels were
significantly increased or decreased in the OBs of old compared to young mice (Poon et al.
2005b). In this study, I determined the carbonylation status of these proteins as well as several
whose steady-state levels were unchanged but that were carbonylated. Two proteins that whose
steady-state levels were significantly up-regulated, ATP5A1 and FTH, were also carbonylated in
OBs from both 1.5- and 20-month old mice. DNM1, whose steady-state level was significantly
down-regulated, was also carbonylated in OBs from both 1.5- and 20-month old mice. DNM1
and ATP5A were also found to be targets of protein carbonylation in another study of young vs.
old mouse brains (Soreghan et al. 2003); DNM1 was shown to be carbonylated in whole brains
of both young and old mice, while the lipofuscin-related ATP5A1 was carbonylated in the brains
of young mice only. Our different results on these proteins in the OB suggest the occurrence of
regional differences in targets of protein oxidation during brain aging.
The expression of FTH, an oxidative stress-response protein that plays a key role in iron
homeostasis, was significantly increased in the OBs of old mice (Poon et al. 2005b), consistent
with its increase in other brain regions with aging (Connor et al. 1995);(Zecca et al. 2004). In
this study, I demonstrated additionally that FTH immunostaining is most abundant in the 20month old, intermediate in the 6-month old, and lowest in the 1.5-month old; that FTH is
carbonylated in the OBs of 1.5- and 20-month old mice, and that it is localized primarily in
mitral/tufted cells, the second-order neurons in the transmission of olfactory information to
higher brain centers.

Our results suggest that mitral/tufted cells are targets of age-related

oxidative stress that may result in functional deficits in the transmission of olfactory information
to higher brain centers, contributing to the age-related decline in olfactory function.
Two of the previously identified proteins, CAPN12 and RLBP1, were carbonylated in the
OBs of 20-month old mice only, although differences in protein-bound carbonyls and degree of
oxidation when compared with OBs from 1.5-month old mice were not significant. However,
their oxidation suggests the possibility of functional alterations of their activity in the OBs of the
older mice. CAPN12 was identified as a specific target of protein nitration in the cerebral cortex
of Tg2576 transgenic mice that express high levels of a mutated human β-amyloid precursor
protein (Shin et al. 2004). Calpains are Ca2+-activated proteolytic enzymes that have been
implicated apoptosis in neurons and astrocytes (Raynaud and Marcilhac 2006); an oxidationmediated reduction in enzyme activity may contribute to inefficient or incomplete apoptosis of
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functionally impaired cells. RLBP1 (CRABP1) has been localized in scattered glomerular and
granule cells in the murine OB (Rawson and LaMantia 2006), and non-dopaminergic
periglomerular cells express very high levels of retinoic acid (RA)-synthesizing enzymes
(Wagner et al. 2002), suggesting that RA modulates neuronal function and maintenance.
Oxidation of RLBP1 may reduce its ability to modulate RA availability in the OB of 20-month
old animals, contributing to RA-mediated aging pathology (Rawson and LaMantia 2006).
The other proteins whose expression was altered in the old vs. young mice, i.e., RAB14,
ENO1, TPM3 and MDH1, did not have corresponding spots on any of the 9 oxyblots, indicating
that they were not detectably carbonylated. This emphasizes that specific proteins are targets for
carbonylation and suggests that in the aging OB, steady-state protein levels are regulated by
mechanisms that differ from those that target specific proteins for oxidative modification, and
that integration of data from various levels of protein synthesis and modification is necessary to
fully understand how aging affects these processes.
Immunoreactivity for 3-NT is an indicator of protein oxidation mediated by peroxynitrite,
formed when nitric oxide interacts with superoxide; the resultant free radical reactions result in
the nitration of tyrosine residues (Radi 2004).

There was a gradation in intensity of

immunostaining in the OBs of mice at the 3 ages we examined, with the faintest staining in the
1.5-month olds, intermediate levels in the 6-month olds, and the most intense in 20-month old
mice. Staining was localized primarily in the blood vessels and lipofuscin-containing microglia.
3-NT immunoreactivity was previously demonstrated in endothelial and microglial cells in the
human OB, primarily in the glomerular layer, of elderly subjects and was elevated in AD patients
(Getchell 2002; Getchell 2001a). Nitration as indicated by 3-NT immunoreactivity has been
associated with vascular dysfunction (Luthra et al. 2005; Maneen et al. 2006; Radi 2004);
vascular dysfunction in the OB as in other brain areas may lead to imbalances in ionic
homeostasis (Bailey et al. 2004) with direct effects on neuronal transmission and viability that
would certainly contribute to impaired olfactory function with aging.
I have demonstrated a significant increase in protein oxidation in the OBs of old
compared to young mice, identified specifically carbonylated proteins and the cells in which the
proteins are expressed, and identified sites of increased age-related nitration in the murine OB.
These results strongly support the concept that oxidative stress, which results in oxidative
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modification of specific proteins in identified cells of the OB, is a major mechanism underlying
age-associated olfactory dysfunction.
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Introduction
Many neurodegenerative diseases lead to olfactory sensory decline, yet the molecular
mechanisms underlying this process are still unclear and under investigation.

Olfactory

impairment has been demonstrated to occur with aging in humans (Cerf-Ducastel and Murphy
2003; Doty et al. 1991) as well as in neurodegenerative disorders such as Alzheimer’s,
Parkinson’s, and Huntington’s disease (Mesholam et al. 1998a; Nordin et al. 1995).
Neurodegeneration has been associated with certain molecular and cellular processes that include
elevated oxidative stress/stress response; macromolecular damage including increased DNA
damage, protein oxidation, and lipid peroxidation; mitochondrial metabolic decline; apoptosis
and altered cell cycle dynamics; and increased inflammatory response (Park and Prolla 2005).
Neurons are particularly sensitive to oxidative stress, which can lead to apoptotic cell death
(Krantic et al. 2005; Rego and Oliveira 2003). We have previously shown that oxidative stress
and associated macromolecular damage is a hallmark of olfactory aging and neurodegeneration
(Getchell et al. 2003a; Getchell et al. 2003b; Getchell et al. 2003c; Getchell et al. 1995; Krishna
et al. 1995; Poon et al. 2005b; Vaishnav et al. 2006).
The Harlequin mouse, a model of adult-onset neurodegeneration, carries an X-linked
recessive mutation in the Pdcd8 (programmed cell death 8) gene, the protein product of which is
known as apoptosis-inducing factor (AIF; (Klein et al. 2002; Susin et al. 1999). This protein is
known to have two distinct cellular functions mediated by different molecular domains: first, the
maintenance of normal mitochondrial metabolism and consequently low levels of oxidative
stress in neurons via its oxidoreductase domain, and second, the induction of apoptosis in a
caspase-independent manner via its apoptosis domain. In the Harlequin mouse, the Hq allele of
the Pdcd8 gene contains an intronic proviral DNA insertion in the oxidoreductase domain,
resulting in an 80% reduction in Pdcd8 mRNA and AIF protein expression, increased oxidative
stress, and mitochondrial bioenergetic impairment in several tissues including the brain (Klein et
al. 2002). Interestingly, in the retina and cerebellum of the Harlequin mutant mice, the levels of
the modified DNA base 8-hydroxydeoxyguanosine (8OHdG) increases in various cell types,
leading to increased mutations and apoptotic cell death of certain neurons (Klein et al. 2002;
Stringer et al. 2004; Vahsen et al. 2004).
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Harlequin mice exhibit progressive retinal

degeneration, beginning with the loss of amacrine and ganglion cells at 3 months of age and
extending to all layers of the retina by 11 months. Beginning at 4 months of age, they also
exhibit cerebellar degeneration, including apoptosis of granule cells, with ataxia appearing at
around 5 months and progressing with age (Klein et al. 2002).
In this study, we investigated whether similar oxidative stress-induced neurodegenerative
changes occurred in the olfactory system of the Harlequin mutant mouse, which might then serve
as a model for investigating the mechanisms by which age-associated oxidative stress leads to
olfactory neurodegeneration. Our novel cellular results using six-month old male Harlequin
mutant mice (Hq/Y) and age- and gender-matched littermate controls (+/Y) demonstrated that
elevated oxidative stress, increased apoptotic cell death, and marked cellular degeneration occur
in the olfactory epithelium (OE) of the Hq/Y mutant mouse. Our microarray analyses confirmed
and extended our cellular analyses to the molecular level, demonstrating a significant reduction
in the expression of Pdcd8 and the dysregulation of expression of genes in several relevant
categories, including oxidative stress, apoptosis/cell cycle, cytoskeletal organization, and
neurogenesis, validating the Harlequin mutant mouse as a model in which to investigate
underlying mechanisms of oxidative stress-induced olfactory neurodegeneration.
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Materials and methods

Animal and tissue preparation
A total of 12 mice were obtained from Jackson Laboratories (Bar Harbor, ME): six male
B6CBACa Aw-J/A-Pdcd8-Hq/J (stock number 00501) mutant mice or “Hq/Y” and six
B6CBACa wild-type littermate controls or “+/Y.” The mice were purchased at 13 weeks of age
and were maintained in an animal facility at the University of Kentucky Department of
Laboratory Animal Research (DLAR) until they reached six months of age. At the DLAR, they
were kept on a 12 hr light:dark cycle in Bioclean units with sterile-filtered air and provided food
and water ad libitum. All protocols were implemented in accordance with NIH guidelines and
approved by the University of Kentucky Institutional Animal Care and Use Committee.
The six-month old Hq/Y mutant mice were small (mean body weight 26.0 g), moderately
ataxic, and had patchy to extensive hair loss, primarily on their dorsal side. The six-month old
+/Y controls were larger (mean body weight 39.5 g), exhibited a normal gait, and had a thick
brown coat of fur. One +/Y mouse died of apparent natural causes as the mice aged in the
DLAR facility, resulting in a total of 11 mice used in our study. The number of mice available
for use in our study was limited by the number that met our strict age, gender and littermate
inclusion criteria.
For histology, two mice per group were injected with 5-bromo-2’-deoxyuridine (BrdU;
Sigma-Aldrich, Inc., St. Louis, MO; 100 mg/kg i.p.) in sterile saline, and anesthetized and
perfused with 3% paraformaldehyde two hours later, followed by tissue harvesting (brain, nasal
cavity including olfactory epithelial tissue, eyes, liver and gut), processing and sectioning
(coronal) as previously described (Kwong et al. 2004). For RNA expression analysis, following
euthanasia with CO2, the olfactory epithelium (OE) from the remaining four Hq/Y mice and
three +/Y mice were quickly removed, weighed, and snap-frozen in liquid nitrogen.

Cellular localization of olfactory marker protein (OMP), AIF and 8OHdG
Standard indirect immunofluorescence techniques were used as previously described
(Nan et al. 2001) to visualize the mature olfactory sensory neuronal (mOSN) marker OMP; AIF;
and the DNA damage marker 8OHdG. The goat polyclonal antibody for OMP, a generous gift
of Dr. F. L. Margolis, University of Maryland, Baltimore, MD, was used at a dilution of 1:1,000;
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immunoreactivity was visualized with FITC-conjugated donkey anti-goat IgG (Jackson
ImmunoResearch, West Grove, PA) at a dilution of 1:100. To localize AIF protein, a mouse
monoclonal antibody (E-1, Santa Cruz Biotechnology, Santa Cruz, CA) was used at 1:50
dilution; for 8OHdG, a mouse monoclonal antibody (QED Bioscience Inc, San Diego, CA) was
used at a dilution of 1:500.

For both, immunoreactivity was visualized using FITC- or

Rhodamine Red-X (RRX)- conjugated donkey anti-mouse IgG. For co-localization experiments,
AIF or 8OHdG and OMP antibodies were applied to the sections simultaneously and incubated
overnight. The sections were washed with PBS, incubated with FITC-conjugated donkey antimouse IgG (1:100) for AIF or 8OHdG, washed again, and incubated in RRX-conjugated donkey
anti-goat IgG (1:150) for OMP. Sections stained for AIF, 8OHdG and OMP were examined and
photographed with a Leica TCS SP upright confocal microscope with a DM RXE precision
focusing nosepiece (Leica Microsystems GmbH, Wetzlar, Germany) with argon (green) and
krypton (red) lasers.

To evaluate the amount of autofluorescent lipofuscin, a marker of

(primarily) undegraded oxidized protein, sections were rehydrated in PBS, cover slipped, and
examined through the FITC filter of a Leitz Aristoplan microscope with a xenon light source.
Images were processed with Adobe Photoshop C52 (Adobe Systems, Inc., San Jose, CA).

Cellular localization of apoptotic cells, apoptotic bodies, and macrophages
Peroxidase immunohistochemistry for the apoptotic cell marker cleaved caspase-3 was
performed using the Vectastain Elite ABC Kit according to manufacturer’s directions (Vector
Laboratories, Burlingame, CA). Polyclonal antibody against cleaved caspase-3 (Cell Signaling
Technology, Beverly, MA) was used at a 1:50 dilution. Briefly, endogenous peroxidase activity
was quenched with 7.5% H2O2 in 100% methanol for 30 min. Sections were incubated in diluted
normal blocking serum for 20 min, in the primary antibody for 30 min, in the biotinylated
secondary antibody for 30 min, in the Vectastain Elite ABC reagent 30 min, and finally in the
peroxidase substrate aminoethyl carbazole (AEC; Zymed/Invitrogen, Carlsbad, CA). Sections of
spleen, where numerous apoptotic cells occurred, were stained as positive controls.

For

quantification, cleaved caspase-3 immunoreactive cells were counted in five 250-μm lengths of
OE each on both sides of the septum and on turbinate IIa on one side of the nasal cavity (n = 15
fields). This procedure was performed in three sections per mouse, two mice per strain (Hq/Y
and +/Y). Sections approximately 100 µm apart from the same region of the nasal cavity were
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used for all mice. The number of apoptotic cells in each section was averaged for each mouse,
and box plots that represent the means falling within the 25th to 75th percentiles were generated
from the 6 resultant means from each strain using Sigma Plot (Systat Software, Inc., Richmond,
CA). The medians of the means for each strain were indicated by the horizontal lines in each
box.
To visualize apoptotic bodies, nuclei were stained with bisbenzimide (Hoechst 33258;
Sigma-Aldrich). Sections were incubated in a solution of 1:105 bisbenzimide in PBS for three
min at room temperature, rinsed in PBS, coverslipped and visualized with the Aristoplan
microscope and a broad-band fluorescence filter. To identify macrophages, a mouse monoclonal
antibody for the pan-macrophage marker CD68 (Serotec, Raleigh, NC) was used at a 1:50
dilution and an RRX-conjugated donkey anti-rat IgG (Jackson ImmunoResearch) at a dilution of
1:200.

Characterization of cellular architectural changes
Hematoxylin and eosin staining was used to compare the basic cellular architecture of the
OE, olfactory bulb (OB), cerebellum, and retina of Hq/Y and +/Y mice. To investigate the
appearance of the OE basement membrane, a rabbit polyclonal antibody to α-laminin (1:500
dilution; Sigma-Aldrich) was used, followed by an FITC-conjugated donkey anti-rabbit IgG
(Jackson ImmunoResearch).
Controls in which the primary antibody was omitted from the staining protocol were performed
for all immunohistochemical experiments. In all cases, no staining was observed in the OE.

RNA isolation
Frozen tissue was pulverized in TRI Reagent (Sigma-Aldrich, St. Louis, MO) and
processed through a QIAshredder column (Qiagen, Valencia, CA). The total RNA was further
purified using the Qiagen RNeasy Mini-Kit according to the manufacturer’s protocol. Total
RNA yield and purity was assessed with a spectrophotometer and with the model 2100
Bioanalyzer (Agilent Technologies, Palo Alto, CA); all samples had A260/A280 ratios of 1.9–
2.2 and showed two sharp peaks corresponding to 18S and 28S RNA on the Bioanalyzer
electropherograms.
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High density oligonucleotide arrays
Affymetrix Murine Genome 430 2.0 microarrays (Affymetrix, Santa Clara, CA) were
processed at the University of Kentucky Microarray Core Facility. A total of six GeneChips
(three for Hq/Y mutant and three for +/Y control mice) were used. Following target preparation,
hybridization, and signal acquisition according to standard Affymetrix protocols, the normalized
hybridization signals were analyzed with the Affymetrix Microarray Suite 5.0; a threshold value
of 1,500 was used to normalize the data across all the microarrays. The hybridization signal for
each probe set was assigned an “absolute call” of “Present,” “Marginal,” or “Absent.” To be
included in the subsequent statistical analyses, a probe set was required to be identified as
Present on at least one of the six microarrays and the identity of the gene associated with the
probe set known. The microarray data set was deposited into the Gene Expression Omnibus
(GEO) database; the series accession number is GSE6485.

Statistical Analysis
The mean hybridization signals for all of the Present known genes were analyzed with
two-tailed Student’s t-tests for each gene. Genes that were differentially expressed at two levels
of significance, p < 0.05 and p < 0.01, were used in subsequent analyses; genes that had p-values
of < 0.05 were used only in the bioinformatics analysis (see below). A histogram of the relative
frequencies of p-values of the 20,664 Present known genes was plotted to assess their
distribution; for comparison, a similar histogram was generated for 12,164 Present known genes
from another data set in which olfactory bulbectomy (OBX) was performed as previously
reported (Getchell et al. 2005), and differential gene expression in the olfactory epithelium was
compared in sham-bulbectomized and bulbectomized mice.
A probit transformation was applied to the p-values of all Present known genes. If the pvalues were from a uniform (0,1) distribution, the probit-transformed p-values would follow a
standard normal distribution; if the p-values were not from a uniform distribution, the probittransformed p-values would deviate from the normal distribution. A quantile-quantile (q-q) plot
was generated to assess the normality of the transformed p-values. A one-sided one sample
Kolmogorov-Smirnov (KS) test was also performed to determine if the p-values of the 221 genes
with p < 0.01 were significantly smaller than would be expected by chance.
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Data management was performed with Excel (Microsoft, Redmond, WA), and statistical
and graphic analysis was performed with SAS (SAS Institute, Cary, NC), R software
(http://cran.us.r-project.org/), and SigmaPlot (SPSS, Chicago, IL).

Bioinformatics analysis
Expression Analysis Systematic Explorer (EASE) software (Hosack et al. 2003) was used
to identify significantly over-represented categories in the up- and down-regulated genes with p
< 0.05 among the Present known genes. The descriptors used were the Cellular Component,
Biological Process, and Molecular Function categories as defined by Gene Ontology (GO;
http://www.geneontology.org/).

Real time RT-PCR
Real-time PCR was performed on aliquots of cDNA reverse-transcribed from the same
total RNA that was used for microarray hybridization. The reactions were performed using
cDNA equivalent to 10 ng of RNA, 300 nM each of forward and reverse primers, and
QuantiTect SYBR Green PCR Master Mix (Qiagen) according to the manufacturer’s protocol in
the ABI Prism 7000 Sequence Detection System (Applied Biosystems, Foster City, CA).
Primers for each gene spanned at least one intron, except those for OMP, an intronless gene.
Primer sequences, annealing temperature, amplicon size and melting temperature, and the
citations for the sources of the primers are listed in Table 4.1 (Atsawasuwan et al. 2005; Douglas
and Camper 2000; Li et al. 2006; Siu and Alway 2005). Reaction parameters were as follows: 2
min at 50°C; 15 min at 95°C; 40 cycles of 15 s each at 94°C, 30 s at the appropriate annealing
temperature, and 1 min at 72°C. Control and experimental cDNA, cDNA for the derivation of
standard curves, and no-template controls were run in triplicate. A dissociation curve was
obtained at the end of each reaction to verify the presence of a single product with the
appropriate melting point for each product. The presence of a single product from each reaction
and its size were also confirmed on a 2% agarose gel stained with ethidium bromide. Real time
RT-PCR for OMP mRNA was performed as previously described (Kwong et al. 2004) to
confirm that the total RNA was extracted from OE, and in every case, this was confirmed. The
comparative threshold cycle (CT) method was used to analyze relative changes in gene
expression. The average CT values for each triplicate from each of the three Hq/Y or three +/Y
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mice were evaluated with an unpaired t-test. Relative quantification and fold changes were
calculated using the standard curve method as previously described (Kwong et al. 2004).

Note on terminology
Although the name of the Pdcd8 gene was changed to Aifm1 (apoptosis-inducing factor,
mitochondrion-associated 1) in the NCBI Entrez Gene database in November, 2006, we have
used the previous designation to remain consistent with the terminology used for the Affymetrix
GeneChips and in the current literature.
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Table 4.1. Real-time RT-PCR primers
Target

Pdcd8

Primer Sequence
F:5’CCGGCTTCCAGGCAACTTGTTCC

Primer

Amplicon

Amplicon

Reference

Ta

Size

Tm

60 °C

359 bp

83 °C

(62)

55 °C

114 bp

78 °C

PE*

45 °C

68 bp

80 °C

(44)

45 °C

109 bp

74 °C

(16)

50 °C

486 bp

87 °C

(4)

55 °C

114 bp

80 °C

PE*

R:5’CCCGGATGGATCTGGCTGCTGCA
Cct4

F:5’ TGATTGACCCAGCCACAGCTA
R:5’ TCTGTGTGAGAACGAGGCCTTC

Cxcl12

F:5’CGTGAGGCCAGGGAAGAGT
R:5’TGATGAGCATGGTGGGTTGA

Amph

F:5’ACGAGGGGGCAAAAGAAC
R:5’CAGCATACATCACCTCGTTCA

Loxl2

F:5’GCCCTCCGATGTGGTCAAG
R:5’GCCCTCCTTCACCTCCACGTAG

Parp2

F:5’ TCTGTAACGTGCAGACCATGGA
R:5’ TGAGAGACTGGTAACCGGCCTT

* PE, Primer Express software, Applied Biosystems;
Ta, primer annealing temperature; Tm, amplicon melting temperature.
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Results

Cellular localization of AIF in the OE
AIF is the protein product of Pdcd8, which carries the Harlequin mutation in the Hq/Y
mice.

To demonstrate AIF expression in the OE and qualitatively assess differences in

expression and localization between the mutant Hq/Y and control +/Y mice, we performed
immunofluorescence staining with an antibody to AIF (Figure 4.1).

We observed AIF

immunoreactivity in all layers of the OE in the +/Y controls. The staining appeared punctate and
was localized primarily in the perinuclear region and dendrites of mOSNs (Figure 4.1A), which
coincides with the reported primary sites of localization of mitochondria in OSNs (Naguro and
Iwashita 1992). In contrast, in the Hq/Y mutant mice, immunoreactivity for AIF was negligible
in most regions of the OE (Figure 4.1B). However, on some turbinates, clusters of strongly
immunoreactive cells were observed (Figure 4.1C). These cells exhibited a very different pattern
of immunoreactivity than those in the +/Y mice in that the staining was more diffuse and less
punctate, apparently cytosolic, suggesting the possible translocation of AIF out of the
mitochondria, and was more concentrated in the supranuclear region of the OSNs. These results
demonstrated that AIF was abundant and most likely mitochondrial in the +/Y controls, whereas
although it was seldom observed in the Hq/Y mutant OE, it was most likely cytosolic in the cells
in which it occurred.
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Figure 4.1. Immunofluorescence staining for apoptosis-inducing factor (AIF) in the olfactory
epithelium (OE). Representative confocal images are shown for a 6-month old Harlequin mutant
mouse (Hq/Y) and its littermate control (+/Y). AIF-immunoreactive cells were seen in the OEs
of both Hq/Y mutants and +/Y controls. Punctate staining was observed throughout the OE of
+/Y controls (A), primarily the perinuclear region and at the surface in what appeared to be
dendrites (arrows) of the mature olfactory sensory neurons (mOSNs). In the Hq/Y mutant mice,
AIF was undetectable in majority of the OE (B), with the exception of infrequent clusters of
immunoreactive cells resembling mOSNs on certain turbinates (C, arrows) which exhibited
intense cytosolic staining. Calibration bars: 20 μm
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Oxidative damage in the Harlequin mutant mouse OE
The decreased abundance of AIF in Hq/Y mutant mice was reported to increase their
susceptibility to oxidative stress-associated DNA damage and apoptosis in the retina and
cerebellum (Klein et al. 2002). To assess whether there was an increase in oxidative DNA
damage in the OE of Hq/Y mutant mice, I performed immunofluorescence staining for 8OHdG,
a marker of oxidative DNA damage, in sections near-adjacent to those in which AIF was
localized (Figure 4.2). While 8OHdG was undetectable in the OE of +/Y controls (Figure 4.2A),
we observed numerous strongly immunoreactive cells in the OE of Hq/Y mutant mice (Figure
4.2B).

The 8OHdG immunoreactivity in the Hq/Y mutants was primarily extranuclear,

suggesting increased mitochondrial oxidative DNA damage. Large numbers of 8OHdG positive
cells were observed in the OE on both on the septum and turbinates. The shape and location of
most of the immunoreactive cells suggested that they were likely to be OSNs.

The

autofluorescent pigment lipofuscin, which indicates the cellular accumulation of oxidized
macromolecules, primarily proteins, also differed in abundance and localization in the Hq/Y
mutant and +/Y control mice. In the +/Y control mice, a small amount of lipofuscin was
confined to a region near the OE basement membrane (Figure 4.3A); in contrast, in the Hq/Y
mouse, a large amount of lipofuscin, distributed throughout the OE, was concentrated in the
lower quarter of the epithelium (Figure 4.3C).

Taken together, these results demonstrate that

there is elevated DNA and protein oxidative damage in the OE of the Hq/Y mutant mouse
compared to the +/Y controls.
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Figure 4.2.

8-Hydroxydeoxyguanosine (8OHdG) immunofluorescence in the olfactory

epithelium (OE). Representative confocal images of OE sections adjacent to those stained for
AIF and stained with an antibody to 8OHdG are shown (A, B). In the +/Y controls (A),
negligible immunoreactivity for 8OHdG was observed. In contrast, in the Hq/Y mutant mice,
numerous cells resembling mature olfactory sensory neurons (mOSNs) were strongly
immunoreactive for 8OHdG (B, arrows). A photomicrograph of the Hq/Y mutant OE taken with
a standard fluorescence microscope showing a representative no-primary control (C) shows
negligible staining. Calibration bars: A and B, 20 μm; C, 25 μm.
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Figure 4.3. Increased lipofuscin and macrophage infiltration in the olfactory epithelium (OE) of
Harlequin mutant mice. Faint autofluorescent lipofuscin was observed in the basal cell layer of
the OE of 6-month old +/Y control mice, apparently in the foot processes of sustentacular cells
(A).

In contrast, intense lipofuscin autofluorescence was present, apparently in the foot

processes of the sustentacular cells, as well as throughout the epithelium in the Hq/Y mutant
mice (C). A few CD68-positive macrophages (e.g., arrow, B) were present in the OE and lamina
propria of +/Y control mice; a pronounced increase in the number of CD68-positive
macrophages (e.g., arrows, D) was observed in both the epithelium and the lamina propria in
Hq/Y mutant mice. Calibration bar, 25 μm.
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Localization of AIF and 8OHdG in mOSNs
Both AIF and 8OHdG were localized in the OE, primarily in cells that resembled OSNs.
To determine whether AIF and 8OHdG were localized in mOSNs, I performed double
immunofluorescence staining with antibodies for each of these proteins and for OMP (Figure
4.4). We observed striking differences in the localization of AIF between the +/Y controls and
the Hq/Y mutant mice. In the +/Y controls, the widespread punctate immunoreactivity for AIF
(Figure 4.4A), when merged with the immunoreactivity for OMP (Figure 4.4B), largely colocalized with OMP (Figure 4.4C, yellow), both in the perinuclear cytosol and dendrites of
mOSNs. Although AIF-immunoreactive cells were seldom observed in most of the OE of Hq/Y
mutant mice, the occasional strongly AIF-immunoreactive cells (Figure 4.4D), when merged
with OMP immunoreactivity (Figure 4.4E), were usually also OMP-positive (Figure 4.4F,
yellow), confirming the localization of AIF in mOSNs. Unlike the +/Y controls, no punctate
mOSN dendritic immunoreactivity was detected in the Hq/Y mutants.

These novel results

demonstrated that AIF was expressed by mOSNs both in the +/Y control and the Hq/Y mutant
mice but that the numbers of AIF-immunoreactive neurons and the pattern of intracellular
localization differed between the mutants and controls.
Immunoreactivity for the DNA damage marker 8OHdG was negligible in the +/Y control
mice (Figure 4.4G), and when merged with OMP immunoreactivity (Figure 4.4E), negligible colocalization was observed (Figure 4.4I). In contrast, numerous cells strongly immunoreactive for
8OHdG (Figure 4.4J) occurred in the Hq/Y OE, the majority of which were also immunoreactive
for OMP (Figure 4.4K, L). The co-localization of 8OHdG and OMP observed in the Hq/Y OE
was primarily in the supranuclear region, and punctate 8OHdG also co-localized with OMP in
some mOSN dendrites, consistent with the reported location of mitochondria in mOSNs. These
results demonstrated that oxidative DNA damage, which was negligible in the +/Y controls, was
highly elevated in the mOSNs of the Hq/Y mutant mice.
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Figure 4.4. Co-localization of apoptosis-inducing factor (AIF) and 8-hydroxydeoxyguanosine
(8OHdG) with olfactory marker protein (OMP) in the olfactory epithelium (OE). AIF (A-F).
AIF immunoreactivity is localized in the perinuclear region and dendrites (green, A) of cells that
resemble mature olfactory sensory neurons (stained for OMP, red, B) in +/Y controls. Colocalization of AIF and OMP is confirmed in (C), in which mOSNs appear yellow (C) in the
merged images. In Hq/Y mutants, infrequent clusters of AIF-positive cells (green, D) resemble
mOSNs (red, E). Co-localization is demonstrated in the merged image (yellow, F). 8OHdG (GL). There was negligible 8OHdG immunoreactivity in the OE of +/Y control mice (G), although
OMP-positive mOSNs (red, H) were abundant. There was negligible evidence of co-localization
(I, yellow).

In the Hq/Y mutant mouse, numerous 8OHdG-positive cells were observed

throughout the OE (green, J) that resembled mOSNs (red, K). Co-localization (yellow, L)
confirmed that most of the cells showing oxidative DNA damage were mOSNs. Calibration bar,
20 μm.
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Apoptosis in the OE of Harlequin mutant mice
Increased oxidative DNA and protein damage predisposes neurons to apoptotic cell
death. To determine whether there was an increase in apoptotic cell death concomitant with the
increased oxidative DNA damage in the OE of the Hq/Y mutant mice, I performed
immunohistochemistry for the cleaved (active) form of the apoptosis effector caspase-3 (Figure
4.5).

In a typical section of OE from the +/Y control mice, we observed no caspase-3

immunoreactive cells (Figure 4.5A). In contrast, numerous cleaved caspase-3 positive cells were
present throughout the OE of the Hq/Y mutant mice (Figure 4.5C). Quantification of the
apoptotic cells is presented by box plots (Figure 4.5E), in which the boxes show the spread of the
means of the number of cleaved caspase-3-positive cells between the 25th and 75th percentiles in
the two strains of mice. The median of the mean numbers of apoptotic cells, as shown by the
horizontal line in each box, was higher in the OE of Hq/Y mutants than in +/Y controls. The
mean number of cleaved caspase-3 positive cells was 3.4-fold higher in the OE of Hq/Y mutant
mice compared to +/Y controls, demonstrating an increase in apoptosis. Apoptotic bodies,
demonstrated by bisbenzimide staining of near-adjacent OE sections from +/Y control and Hq/Y
mutant mice (Figure 4.5B, D, and F respectively) were more abundant in the Hq/Y mutant mice
than in +/Y controls, confirming our results with cleaved caspase-3. Also consistent with these
results, there was a 1.6-fold greater number of CD68-positive macrophages, which are
scavengers of apoptotic cells in the OE (Getchell et al. 2006; Suzuki et al. 1995), in the OE of
Hq/Y mutants compared to +/Y controls (Figure 4.3 B, D).
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Figure 4.5. Cellular analysis of apoptosis in the Harlequin mouse olfactory epithelium (OE).
Cleaved caspase-3 immunoreactivity (A, C, E). Typically, no cells immunoreactive for cleaved
caspase-3 were observed in the OE of +/Y control mice (A). In the Hq/Y mutant mice (C),
cleaved caspase-3-immunoreactive cells (black arrows) occurred throughout the OE.

A

comparison of the mean numbers of apoptotic cells in the two strains is represented in the box
plots (E), where each box represents the values of the means of the numbers of apoptotic cells
that fell within the 25th to 75th percentiles (see text for details). The horizontal line in each box
indicates the median of the mean numbers of apoptotic cells in the +/Y controls (left) and Hq/Y
mutants (right), confirming that there were more apoptotic cells in the OE of the mutants than
controls. Bisbenzimide staining (B, D, F). Sections near those stained for cleaved caspase-3
immunoreactivity were stained with bisbenzimide to visualize apoptotic bodies, which were
more abundant in the OE of the Hq/Y mutants (D, white arrows, and enlarged inset, F) compared
to +/Y controls (B, white arrow). Calibration bars: 25 μm.
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Other cellular changes in the OE of Hq/Y mice
To assess the general cellular organization of the olfactory mucosa in the Hq/Y mutants
compared to the +/Y controls, sections were stained with hematoxylin and eosin (Figure 4.6A,
C). The major differences were the apparent presence of discontinuities in the OE basement
membrane with a resultant lack of a clear delimitation of the OE from the lamina propria, and an
apparent disaggregation of the olfactory nerve bundles (ONBs) in the lamina propria. To assess
the integrity of basement membranes in the olfactory mucosae of Hq/Y and +/Y mice,
immunoreactivity for α-laminin was compared. The OE basement membrane (arrowheads) was
relatively distinct in the +/Y control (Figure 4.6B), but appeared diffuse and highly
discontinuous in the Hq/Y mutant (Figure 4.6D). Additionally, the large ONBs with thick αlaminin-containing basement membranes evident in the +/Y controls are replaced by smaller,
less distinct ONBs in the Hq/Y mutants.

Oxidative changes in the olfactory bulbs (OBs) of Hq/Y mutant mice
Because of the increased incidence of oxidative stress that we demonstrated in the
mOSNs of Hq/Y mutant mice, we investigated the second-order targets of the mOSNs, the mitral
cell neurons, in the OBs of the mutant and control mice. Cresyl violet staining to demonstrate
the general organization of the mitral cell layer (Figure 4.7) suggested a somewhat decreased
cellularity in the Hq/Y mutants (Figure 4.7D) compared to the +/Y controls (Figure 4.7A). In
contrast to the lack of changes in the OB reported by Klein et al. (Klein et al. 2002), we observed
a clear increase in oxidative DNA damage, as indicated by 8OHdG staining, in the mitral cells of
the Hq/Y mutants (Figure 4.7E) compared to that in the +/Y controls (Figure 4.7B). Similarly,
lipofuscin, indicative of the accumulation of primarily oxidized protein, was more abundant in
the mitral cell layer of the Hq/Y mutants (Figure 4.7F) compared to the +/Y controls (Figure
4.7C). We observed no cleaved caspase-3 staining in the OBs of either the Hq/Y mutant or +/Y
control mice (not shown).
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Figure 4.6. Laminar disorganization in the olfactory epithelium (OE) of Harlequin mutant mice.
Hematoxylin and eosin (H&E, A, C) staining and α-laminin immunofluorescence (B, D) are
shown for +/Y controls and Hq/Y mutant mice. H&E shows the disaggregation of olfactory
nerve bundles (e.g., asterisk) in the Hq/Y mutant mouse OE (C) compared to +/Y controls (A).
The discontinuous nature of the basement membrane (arrowheads) is indicated in the Hq/Y
mutant compared to control mouse OE by H&E staining (A, C) and confirmed by α-laminin
immunofluorescence (B, D). Calibration bar, 25 μm.
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Figure 4.7. Oxidative damage in the mitral/tufted cell layer (MCL) in olfactory bulbs (OBs) of
Harlequin mutant mice. Cresyl violet staining (A, D), 8-hydroxydeoxyguanosine (8OHdG, B, E)
immunofluorescence, and autofluorescent lipofuscin (C, F) in sections of OB from +/Y control
(upper panel) and Hq/Y mutant (lower panel) mice are shown. Immunoreactivity for 8OHdG (B,
E) was localized in mitral/tufted cells, shown by cresyl violet staining (A, C) of near-adjacent
sections. Sparse cytoplasmic 8OHdG immunoreactivity is localized in mitral/tufted cells in +/Y
control mice (B, arrows).

More intense cytoplasmic 8OHdG immunoreactivity occurs in

mitral/tufted cells in Hq/Y mutant mice (E, arrows). Lipofuscin (gold), an autofluorescent
marker of primarily oxidized protein , , was more abundant and intense in the MCL of Hq/Y
mutant mice (F, arrows) compared to the +/Y controls (C, arrows). EPL, external plexiform
layer; IPL, internal plexiform layer; GCL, granule cell layer. Calibration bar, 25 μm.
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Confirmation of cellular changes in the cerebellum and retina of the Hq/Y mutant mice
To confirm that the Hq/Y mutants from which we obtained olfactory tissues showed the
hallmark changes in the cerebellum and retina that were characterized by Klein et al. (Klein et al.
2002), I stained these tissues with cresyl violet and compared them to the +/Y controls. In the
cerebellum, (Figure 4.8A, B), there is an apparent decrease in the cellularity of the proximal
molecular, Purkinje, and granule cell layers and an increase in vacuolation in the Purkinje cell
layer in the Hq/Y mutants compared to the +/Y controls. In the retina, the overall thickness was
substantially reduced and was accompanied by an apparent reduction in the thickness of all
layers. We also observed an increase in the number of cleaved caspase-3 immunoreactive cells
in the retinas of Hq/Y mice (not shown).
In summary, these novel cellular results have demonstrated the expression of AIF in
mOSNs in +/Y control mice and a substantial decrease in its abundance in the Hq/Y mutants. In
addition, I have demonstrated a substantial increase in markers of oxidative stress in mOSNs and
other cells in the OE as well as an increased number of apoptotic cells in the OE of the Hq/Y
mutant mice compared to +/Y controls. These cellular results provided a framework for our
microarray and bioinformatics analyses, which begin to elucidate the mechanisms underlying
oxidative stress-associated changes in the OE of the Harlequin mice.
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Figure 4.8. Degenerative changes in the cerebellum and retina of Harlequin mice. Cresyl violet
staining of sections of cerebellum (upper panel) and retina (lower panel) for 6-month old +/Y
control (A, C) and Hq/Y mutant (B, D) mice is shown. Distinct cellular layers were observed in
the cerebellum of +/Y control mice (A), namely the molecular layer (ML), purkinje cell layer
(PCL) and granule cell layer (GrCL). Unlike the +/Y control, all cellular layers of the Hq/Y
mouse cerebellum were less dense, particularly the GrCL (B). In addition, prominent vacuolation
was observed in the ML and PCL (B). The retina of the 6-month old +/Y control mice clearly
showed all layers, namely the ganglion cell layer (GCL), inner plexiform layer (IPL), inner
nuclear layer (INL), outer plexiform layer (OPL), outer nuclear layer (ONL) and retinal pigment
epithelium (R). In the Hq/Y mutant mice, a decrease in cellularity was observed in all layers,
and a concomitant decrease in overall retinal thickness was observed. Calibration bar, 25 μm.
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Microarray analysis and identification of regulated genes in the OE of Hq/Y mice
The flowchart (Figure 4.9) outlines the data scrubbing and statistical analysis of
GeneChip data obtained from three Hq/Y mutant and three +/Y control mouse OEs to identify
significantly regulated genes. We began by removing the 64 quality control probe sets and
17,635 probe sets representing expressed sequence tags (ESTs) and other non-annotated genes
from the 45,101 probe sets on the MG 430 2.0 whole mouse genome GeneChip. An absolute
call analysis on the remaining 27,402 probe sets resulted in the identification of 20,664 known
genes that were Present on at least one of the six GeneChips; of these, 1,019 had p-values < 0.05,
with 488 up-regulated and 531 down-regulated. For subsequent analyses (with the exception of
the bioinformatics analysis), the level of significance was set at p < 0.01 to reduce the number of
potential false positives; 221 genes had p-values < 0.01, with 107 up-regulated and 114 downregulated. Most importantly, the microarray data indicated that the Pdcd8 gene, which encodes
AIF protein, was significantly down-regulated by 4.8-fold in the OE of Hq/Y compared to +/Y
mice (p = 7.3E-05; Figure 4.10).
In order to visualize the distribution of p values resulting from the Hq/Y vs. +/Y
comparison, a histogram of the relative frequencies of the p-values of the 20,664 Present known
genes was generated. The histogram (Figure 4.11A) showed a very different distribution of pvalues for the Hq/Y vs. +/Y data set than those obtained from previous data from several of our
experiments in which a manipulation such as olfactory bulbectomy (OBX) was performed (e.g.,
Figure 4.11B). OBX results in anterograde OSN degeneration, an innate immune response, and
epithelial remodeling, which are responses that induce the coordinated, short-term regulation of
many genes (Getchell et al. 2006; Getchell et al. 2005); this is reflected in the skewing of the
histogram toward low p-values (Figure 4.11B). In contrast, the single gene mutation in the Hq/Y
mice that resulted in an 80% reduction in Pdcd8 expression resulted in the significant regulation
of a relatively small number of genes (Figure 4.11A).
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Figure 4.9. Flowchart summarizing experimental design and results of microarray analysis to
identify significantly regulated genes in the Hq/Y mutant mice compared to +/Y controls. Probe
sets/genes included and statistical test used in the analysis are indicated in bold.
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Figure 4.10. Regulation of Pdcd8 gene expression. Microarray analysis demonstrated that there
was a highly significant (p = 7.3E-05) 4.8-fold down-regulation of the mean hybridization
signals of the Pdcd8 gene in the Hq/Y mutants compared to +/Y controls. ***, p < 0.001; SEM,
standard error of the mean; n = 3 per group.
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Figure 4.11. Histograms of relative frequencies of p-values.
A. Histogram of relative frequencies of p-values of Present known genes in the olfactory
epithelium (OE) from the Hq/Y vs. +/Y microarray analysis. The bin for genes with p < 0.01 is
indicated by a white arrowhead. B. Histogram of relative frequencies of p-values of Present
known genes in the OE from an experiment in which olfactory bulbectomy was performed (see
text for details). Note the difference in the pattern of distribution of p-values in A and B.
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In order to more closely examine the distribution of genes with low p-values, a probit
transformation was performed on the p-values for the 20,664 Present known genes, and a normal
probability or quantile-quantile (q-q) plot of the observed vs. theoretical transformed p-values
(Figure 4.12A) was generated. This analysis clearly showed that the genes with the lowest
transformed p-values deviated from a normal distribution (diagonal straight line), as seen in the
inset showing the quantiles of the probit-transformed p-values for the 221 genes with p < 0.01.
Additionally, a one-sided one sample KS test indicated that the 221 genes had significantly (p <
0.05) smaller p-values than would be expected if they were from a uniform distribution.
Another way of representing the distribution of p-values is a volcano plot (Figure 4.12B),
which illustrates the relationship between the p-value (represented on the y-axis as –log10) and
fold change in expression (represented on the x-axis as log2) for each of the 20,664 Present
known genes. The p-values for genes that fell above the gray dashed horizontal line were less
than 0.05, and for those above the black dashed horizontal line were less than 0.01. Most of the
221 significantly regulated genes (p < 0.01, open black circles) were up- or down-regulated less
than 2-fold (quadrant 2). Genes up-regulated 2-fold or more are shown in quadrant 1, and genes
down-regulated 2-fold or more are shown in quadrant 3 (listed in Table 4.2). More genes were
down-regulated greater than 2-fold than were up-regulated greater than 2-fold. Two genes, Klc2
and Cd99l2, had p-values lower than that of Pdcd8. Klc2 (kinesin light chain 2, p = 9.2E-06,
quadrant 1), whose protein product is involved in the tethering of axonal vesicles to microtubules
for intraneuronal transport (Frederikse et al. 2004), was up-regulated 2.2-fold. Cd99l2 (CD99
antigen-like 2, p = 1.9E-05, quadrant 3), which is highly expressed in neurons (Suh et al. 2003),
was down-regulated 4.8-fold.
To understand the functional significance of the changes in gene expression in the Hq/Y
mutant mice, we performed bioinformatics analysis on the significantly regulated genes in two
ways, both of which relied on functional categories assigned by GO. First, we performed a
broad classification of the significantly regulated genes (p < 0.01) based on a combination of GO
functional category descriptors and literature searches. Second, we used EASE to identify
significantly over-represented categories among the up-regulated and down-regulated genes
based GO categorical systems. The first approach, the results of which are illustrated as a pie
chart (Figure 4.13) and listed in Table 4.2 and 4.3, demonstrated that the majority of these genes
belonged to the neurodegeneration-associated categories of apoptosis/cell cycle, oxidative stress,
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and extracellular matrix/transport. A subset of these genes, which were up- or down-regulated 2fold or more are listed (Table 4.4), under their primary functional category.

The second

approach was to use EASE analysis (Table 4.5), which is based on the number of significantly
regulated genes (p < 0.05) in a particular category compared with the remaining Present known
genes. The EASE results demonstrated that significantly up-regulated genes were associated
with the mitochondrion, nucleus and endoplasmic reticulum, cellular sites that are particularly
involved in oxidative stress responses. The majority of the genes in the co-enzyme prosthetic
group metabolism/porphyrin Biological Process group are electron transport-associated,
emphasizing the involvement of AIF in mitochondrial function and oxidative stress.
Significantly down-regulated genes indicate cytoskeletal breakdown and decreased neurogenesis
as well as transcriptional repression.
Genes for validation with real time RT-PCR were selected based on the p-value/fold
change relationship as shown in the volcano plot (Figure 4.12B, red and blue circles) and on their
relationship to relevant categories as indicated by the bioinformatics analyses (Figure 4.13, Table
4.2).
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Figure 4.12. Graphical analyses of microarray data.
A. The normal probability or quantile-quantile (q-q) plot of the probit-transformed p-values for
all Present known genes. The graph demonstrates that although the majority of the transformed
p-values followed a normal distribution (diagonal straight line); the lowest transformed p-values
deviated from the line. The inset illustrates the deviation of the transformed p-values of the 221
genes with p < 0.01 from the normal distribution. B. Volcano plot of Present known genes
shows the relationship between p-values (expressed as –log10) and fold changes (expressed as
log2). The dashed gray horizontal line is p = 0.05; the dashed black horizontal line is p = 0.01.
The 2 dashed vertical lines equal 2 fold down-regulated expression (left) and up-regulated
expression (right). The genes in quadrant 1 have p < 0.01 and are up-regulated 2-fold or more,
the genes in quadrant 2 have p < 0.01 and are up- or down-regulated less than 2 fold, and the
genes in quadrant 3 have p < 0.01 and are down-regulated 2 fold or more. Genes selected for
validation with real time RT-PCR are shown in red (down-regulated) and blue (up-regulated).
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Table 4.2. Genes down-regulated with p < 0.01
Probeset ID
p-value
Apoptosis/Cell cycle
1418127_a_at
7.29E-05
1452911_at
2.47E-04
1418880_at
3.24E-04
1427940_s_at
3.35E-04
1447913_x_at
3.54E-04
1456375_x_at
9.86E-04
1456482_at
1.40E-03
1420579_s_at
1.75E-03
1432614_at
1.89E-03
1448986_x_at
2.24E-03
1425492_at
2.35E-03
1455717_s_at
2.96E-03
1459736_at
3.35E-03
1417814_at
3.53E-03
1455564_at
3.53E-03
1435233_at
3.69E-03
1416123_at
4.61E-03
1418152_at
5.13E-03
1429123_at
5.38E-03
1449175_at
7.05E-03
1426314_at
7.16E-03
1428777_at
7.58E-03
1420555_at
7.77E-03
1429444_at
7.97E-03
1423059_at
8.25E-03
1456220_at
8.46E-03
1428119_a_at
9.62E-03
Oxidative
stress
1456082_x_at
1.30E-03
1426990_at
2.71E-03
1416421_a_at
3.08E-03
1423997_at
3.25E-03
1454624_at
3.83E-03
1448363_at
4.10E-03
1439457_x_at
5.75E-03
1425451_s_at
5.76E-03
1418835_at
5.98E-03

FC

Gene symbol

4.72
1.41
1.52
1.21
1.65
1.19
1.04
1.23
1.37
1.56
1.14
1.31
5.88
1.33
1.26
1.11
2.18
1.19
1.68
1.74
1.33
1.41
1.84
1.72
1.25
1.44
1.34

Pdcd8*
Spred1
Gfra3
Mycbp
Akap9
Trim27
Pik3r3
Cftr
Wdr37
Dnase2a
Bmpr1a
Daam2
Stk10*
Pla2g5
Bcr
Ncoa2
Ccnd2*
Nsbp1
Rab27a
Gpr65
Ednrb
Spred1
Alx3
Rasl11a
Ptk2
Fbxl7
Rap2c

2.08
3.35
1.17
1.11
1.19
1.17
2.44
3.84
1.59

Cct4*
Cubn*
Ssb
Csde1
Dennd2a
Yap1
Atg12*
Chi3l3 /// Chi3l4*
Phlda1

103

1420788_at
1425450_at
1451005_at
1453928_a_at
Extracellular
matrix/transport
1421462_a_at
1458524_at
1453124_at
1431375_s_at
1433833_at
1429540_at
1431004_at
1417902_at
1450740_a_at
1420484_a_at
1458403_at
1417847_at
1449563_at
1440799_s_at
1436062_at
Protein
synthesis
1429303_at
1460006_at
1436392_s_at
1420650_at
1418820_s_at
1423670_a_at
1435664_at
1436938_at
1452932_at
1459393_at
1416469_at
1444679_at
1448760_at
1450080_at
1452052_s_at
1457834_at
1424573_at
1435870_at
1416224_at

6.89E-03
7.89E-03
8.04E-03
9.53E-03

1.61
5.39
1.10
1.17

Klrg1
Chi3l4*
Sumo1
Ssb

1.63E-03
1.64E-03
2.08E-03
2.21E-03
2.34E-03
2.75E-03
2.90E-03
2.93E-03
3.29E-03
3.40E-03
4.84E-03
5.03E-03
6.60E-03
7.31E-03
7.78E-03

1.64
2.43
1.14
1.13
1.07
1.64
1.91
1.34
1.07
3.55
1.90
1.08
1.52
1.29
1.31

Lepre1
Fndc3a*
Tnpo3
Parva
Fndc3b
Cnfn
Loxl2
Slc19a2
Mapre1
Vtn*
Tnik
Ulk2
Cntn1
Farp2
Arcn1

3.65E-04
3.71E-04
4.23E-04
5.64E-04
7.25E-04
1.13E-03
1.28E-03
1.51E-03
1.73E-03
3.04E-03
3.23E-03
6.55E-03
7.17E-03
7.19E-03
7.53E-03
7.56E-03
8.59E-03
9.02E-03
9.02E-03

1.58
1.18
1.53
1.27
1.34
1.07
1.20
1.28
1.20
1.94
1.37
1.43
1.21
1.31
1.19
1.29
2.24
1.37
1.19

Zfp393
Atbf1
Tcfap2c
Atbf1
Zcchc10
Srpr
Zfp397
Rbms3
Zbtb7a
Tcfap2b
Luzp1
Bhc80
Zfp68
Cxx1c
Eif3s1
Yy1
Tmed5*
Sycp3
Zbtb17
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1454846_at
9.60E-03
1456617_a_at
9.61E-03
Other
1456746_a_at
1.92E-05
1424782_at
3.84E-04
1417776_at
5.55E-04
1450691_at
5.56E-04
1456747_x_at
8.99E-04
1426856_at
1.02E-03
1441455_at
1.08E-03
1455111_at
1.32E-03
1441137_at
1.66E-03
1415704_a_at
1.66E-03
1447943_x_at
1.95E-03
1452479_at
2.06E-03
1418546_a_at
2.08E-03
1456141_x_at
2.12E-03
1450534_x_at
2.17E-03
1422861_s_at
2.34E-03
1434291_a_at
3.00E-03
1425195_a_at
3.02E-03
1458748_at
3.07E-03
1431464_a_at
3.14E-03
1433667_at
3.61E-03
1429447_at
4.61E-03
1447091_at
4.64E-03
1425484_at
4.79E-03
1419523_at
4.80E-03
1430893_at
5.01E-03
1429216_at
5.46E-03
1457763_at
5.62E-03
1449443_at
5.67E-03
1453644_at
6.12E-03
1420719_at
6.46E-03
1436012_s_at
7.21E-03
1435792_at
7.67E-03
1420367_at
8.19E-03
1451122_at
9.02E-03
1453972_x_at
9.40E-03
1431172_at
9.47E-03
1424243_at
9.52E-03
*, down-regulated ≥ 2-fold

1.21
1.23

Utp15
Eif2s2

4.70
1.19
2.77
1.17
2.22
1.26
1.64
1.21
1.15
1.14
1.33
1.87
1.25
1.27
2.07
1.59
1.31
1.20
2.08
1.14
2.38
1.46
1.72
1.37
3.12
7.27
1.33
2.64
1.17
1.09
1.37
1.33
1.98
1.35
1.14
1.51
1.95
1.18

Cd99l2*
Tmem77
Azgp1*
Caskin2
Cd99l2*
Hsdl2
Arpp19
Yipf6
Bicc1
Cdv3
Yeats2
Copg2as2
Stambpl1
MGI:2389572
LOC56628*
Pdlim5
Serf1
Acat2 /// Acat3
Rbm27
Pmm2
Lgi3*
Evc2
Jmjd2c
Tox
Cyp3a13*
Mup1*
Paqr3
Gabrd*
Decr1
Obp1a
Tex15
Scrn2
Csprs
Denr
Idi1
Pparbp
Orc4l
Rwdd4a
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Table 4.3. Genes up-regulated with p < 0.01
Probeset ID
Apoptosis/Cell
cycle
1451781_at
1433438_x_at
1421784_a_at
1422254_a_at
1448510_at
1419208_at
1426047_a_at
1432195_s_at
1448212_at
1456080_a_at
1426829_at
1460295_s_at
1417574_at
1426239_s_at
1436855_at
1457289_at
1455669_at
1444271_at
1451967_x_at
1428677_at
1424174_at
1416027_at
1432176_a_at
1423923_a_at
1450213_at
1433891_at
1437527_x_at
1451829_a_at
1437192_x_at
1441755_at
1456278_x_at
1424294_at
1425588_at
Oxidative
stress
1425982_a_at
1417800_at

p-value

FC

Gene symbol

2.08E-04
2.38E-04
4.57E-04
4.96E-04
9.23E-04
1.20E-03
1.50E-03
2.00E-03
2.11E-03
2.12E-03
2.61E-03
2.72E-03
2.78E-03
3.59E-03
3.91E-03
4.09E-03
4.44E-03
4.99E-03
5.23E-03
5.50E-03
6.25E-03
6.29E-03
6.39E-03
6.50E-03
6.53E-03
7.94E-03
8.25E-03
8.26E-03
8.48E-03
8.81E-03
9.08E-03
9.25E-03
9.70E-03

2.15
5.87
1.07
1.36
1.22
1.83
1.41
1.13
1.18
1.31
1.28
1.33
1.75
1.19
1.31
1.18
1.44
1.44
1.72
1.30
1.25
1.12
1.42
1.36
1.64
1.12
1.28
1.41
1.40
1.51
2.57
1.13
1.71

Nfatc2ip*
Mela*
Efna4
Dyrk1b
Efna1
Map3k8
Ptprr
Ccnl2
Tnfsf5ip1
Tde1
Rxrip110
Il6st
Cxcl12
Arrb2
Ptprs
Nr2e1
Wdr19
Anapc1
Kpnb1
Wdr73
Shkbp1
Pdcd6
Eng
Wdr8
Pde7b
Lgr4
Mcl1
Nf2
Vdac1
Mapk15
Gpr172b*
Ppp4r1
Ptprj

1.84E-04
1.51E-03

2.06
1.58

Wrn*
Parp2
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1431948_a_at
1415735_at
1418699_s_at
1446461_at
1417184_s_at
1428168_at
1452230_at
1416618_at
1422627_a_at
1425859_a_at
1456015_x_at
1418172_at
1422715_s_at
1418700_at
1417714_x_at
Extracellular
matrix/transport
1431487_at
1451724_at
1427044_a_at
1419764_at
1435009_at
1416997_a_at
1424735_at
1416529_at
1431646_a_at
1460390_at
1450984_at
1421315_s_at
1438559_x_at
1434801_x_at
1425731_at
1423550_at
1416065_a_at
1427260_a_at
1417750_a_at
Protein
synthesis
1455407_at
1428869_at
1451101_a_at
1427309_at

2.36E-03
4.39E-03
5.42E-03
5.90E-03
6.01E-03
6.98E-03
7.02E-03
7.30E-03
7.39E-03
7.73E-03
8.25E-03
8.77E-03
9.04E-03
9.39E-03
9.84E-03

1.17
1.07
1.28
5.09
1.12
1.13
1.46
1.33
1.18
1.10
1.10
1.48
1.23
1.22
1.85

Pank2
Ddb1
Fech
Sox5*
Hbb
Mpzl1
Dnajc10
Ppox
Mkks
Psmd4
Ndufv1
Hebp1
Acp1
Lias
Hba-a1

9.21E-06
2.06E-04
4.89E-04
8.82E-04
1.11E-03
1.54E-03
2.92E-03
3.26E-03
4.09E-03
4.28E-03
4.47E-03
4.56E-03
4.80E-03
6.01E-03
6.73E-03
7.02E-03
8.27E-03
9.08E-03
9.98E-03

2.21
1.18
1.59
4.60
1.23
1.25
1.22
1.28
1.27
1.30
1.16
1.11
1.58
1.12
1.55
1.29
2.17
1.21
1.38

Klc2*
Ankmy2
Amph
Chi3l3*
Slc9a6
Hap1
Slc25a25
Emp1
Stx6
Sorl1
Tjp2
Cttn
Slc44a2
Slc25a5
Ankrd24
Slc1a4
Ankrd10*
Tpm3
Slc25a37

2.40E-03
2.87E-03
3.08E-03
3.54E-03

1.40
1.11
1.06
1.21

Zfp236
Nolc1
Rps28
Pars2
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1452780_at
5.13E-03
1428494_a_at
5.59E-03
1421986_at
6.32E-03
1455222_a_at
6.72E-03
1452371_at
7.48E-03
1423687_a_at
7.71E-03
1457293_at
8.67E-03
1427500_at
9.23E-03
1435071_at
9.73E-03
Other
1418069_at
2.69E-04
1416222_at
9.47E-04
1424335_at
1.10E-03
1440888_at
2.10E-03
1451755_a_at
2.52E-03
1424304_at
3.03E-03
1422703_at
3.18E-03
1450028_a_at
3.56E-03
1448491_at
3.74E-03
1428166_at
3.79E-03
1448549_a_at
4.72E-03
1448237_x_at
4.94E-03
1440157_at
6.04E-03
1451308_at
6.10E-03
1423418_at
6.15E-03
1426440_at
6.31E-03
1436689_a_at
6.58E-03
1443636_at
6.93E-03
1452361_at
7.00E-03
1421155_at
7.12E-03
1450107_a_at
7.18E-03
1452969_at
7.18E-03
1452708_a_at
7.51E-03
1427956_at
8.07E-03
1458421_at
9.00E-03
*, up-regulated ≥ 2-fold

1.16
1.08
1.36
1.22
1.26
1.12
1.26
1.39
1.34

Gtf3c2
Polr2i
Eif4e2
Ubp1
Sfrs11
Man2c1
Zbtb4
Spcs1
Zfyve1

2.74
1.19
1.23
1.87
1.35
1.96
1.17
1.30
1.21
1.24
1.25
1.08
2.79
1.25
1.16
1.15
1.33
1.46
1.30
1.22
1.32
1.34
1.15
1.16
2.90

Apoc2*
Nsdhl
Ppcdc
Oxtr
Apobec1
Tpcn2
Gyk
Lancl2
Ech1
Cdan1
Dpagt1
Ldh2
Scml4*
Elovl4
Fdps
Dhrs7
Aldh9a1
Abcb9
Rnf20
B3galt6
Renbp
Atp2b1
Luc7l
Pcgf1
Kcnq3*
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Figure 4.13. Categorical analysis. Pie chart shows the classification the 221 significantly
regulated genes (p < 0.01) into functional categories based on Gene Ontology (GO) descriptors
and literature searches.

A total of 60% can be classified in neurodegeneration-associated

categories of apoptosis/cell cycle, oxidative stress, and extracellular matrix/transport.
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Table 4.4. Functional categorization of genes regulated with p<0.01; up- or down-regulated ≥ 2fold in the Hq/Y mutant mouse OE compared to +/Y controls.
Gene name

Gene
Symbol

P-Value

Fold
Change

Pdcd8
Stk10
Ccnd2

7.29E-05
3.35E-03
4.61E-03

- 4.72
- 5.88
- 2.18

Cct4
Cubn
Atg12
Chi3l3 ///
Chi3l4
Chi3l4

1.30E-03
2.71E-03
5.75E-03
5.76E-03

- 2.08
- 3.35
- 2.44
- 3.84

7.89E-03

- 5.39

Fndc3a
Vtn

1.64E-03
3.40E-03

- 2.43
- 3.55

Tmed5

8.59E-03

- 2.24

Cd99l2
Azgp1
Cd99l2
LOC56628
Rbm27
Lgi3
Cyp3a13

1.92E-05
5.55E-04
8.99E-04
2.17E-03
3.07E-03
3.61E-03
4.80E-03

- 4.70
- 2.77
- 2.22
- 2.07
- 2.08
- 2.38
- 3.12

Mup1
Gabrd

5.01E-03
5.62E-03

- 7.27
- 2.64

Nfatc2ip

2.08E-04

2.15

GENES DOWN-REGULATED ≥ 2-FOLD
Apoptosis/cell cycle
programmed cell death 8
Serine/threonine kinase 10 (Stk10), mRNA
cyclin D2
Oxidative stress
chaperonin subunit 4 (delta)
cubilin (intrinsic factor-cobalamin receptor)
autophagy-related 12 (yeast)
chitinase 3-like 3 /// chitinase 3-like 4 (Ym1/2)
chitinase 3-like 4 (Ym1/2)
Extracellular matrix/transport
fibronectin type III domain containing 3a
vitronectin
Protein synthesis
transmembrane emp24 protein transport
domain containing 5
Other
Cd99 antigen-like 2
alpha-2-glycoprotein 1, zinc
Cd99 antigen-like 2
MHC (A.CA/J(H-2K-f) class I antigen
RNA binding motif protein 27
leucine-rich repeat LGI family, member 3
cytochrome P450, family 3, subfamily a,
polypeptide 13
major urinary protein 1
Gamma-aminobutyric acid (GABA-A)
receptor, subunit delta
GENES UP-REGULATED ≥ 2-FOLD
Apoptosis/cell cycle
nuclear factor of activated T-cells,
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cytoplasmic, calcineurin-dependent 2 int. ptn.
melanoma antigen
G protein-coupled receptor 172B

Mela
Gpr172b

2.38E-04
9.08E-03

5.87
2.57

Oxidative stress
Werner syndrome homolog (human)
SRY-box containing gene 5 (Sox5), mRNA

Wrn
Sox5

1.84E-04
5.90E-03

2.06
5.09

Extracellular matrix/transport
kinesin light chain 2
chitinase 3-like 3
ankyrin repeat domain 10

Klc2
Chi3l3
Ankrd10

9.21E-06
8.82E-04
8.27E-03

2.21
4.60
2.17

Apoc2
Scml4
Kcnq3

2.69E-04
6.04E-03
9.00E-03

2.74
2.79
2.90

Protein synthesis
Other
apolipoprotein C-II
sex comb on midleg-like 4 (Drosophila)
potassium voltage-gated channel, subfamily Q,
member 3
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Table 4.5. EASE analysis
UP-REGULATED GENES
Category
Cellular Component
nucleus/nuclear pore
endoplasmic reticulum
mitochondrion
Biological Process
coenzyme-prosthetic group
metabolism/porphyrin metabolism
RNA processing/editing
Molecular Function
transferase activity
intracellular transporter activity

# of
related
categories

List
hits/list
total

EASE
score

5
1
1

96/300
23/300
33/300

2.1E-03
5.5E-03
0.016

5

11/303

0.013

4

18/303

0.014

2
1

10/308
4/308

2.9E-03
0.024

# of
related
categories

List
hits/list
total

EASE
score

2

30/278

0.021

4
4
4

20/276
55/276

8.6E-04
1.7E-03

19/276

3.9E-03

80/292
3/292

0.010
0.037

6//292

0.036

DOWN-REGULATED GENES
Category
Cellular Component
nucleoplasm/transcription factor complex
Biological Process
cytoskeletal organization and biogenesis
regulation of transcription/DNA-dependent
neurogenesis/CNS development/axon
guidance
Molecular Function
nucleic acid binding
protein carrier activity
transmembrane receptor protein kinase
activity
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2
1
1

Molecular validation of gene regulation using real time RT-PCR
We utilized real-time RT-PCR to determine the expression levels of Pdcd8. The gene
was significantly down-regulated in the Hq/Y mutant mice compared to +/Y controls (Table 4.6).
This both validated our GeneChip data for this gene as well as extended results from a previous
report (Klein et al. 2002) in the whole brain and retina, where an 80% down-regulation of the
gene was observed in the mutants.
Genes were critically selected for real time RT-PCR validation based on their biological
relevance to the study, p-values < 0.01, and a robust mean hybridization signal (>100) in all six
animals. We used real time RT-PCR to determine the direction and magnitude of changes in
expression levels for the genes Pdcd8, Cct4 (chaperonin subunit 4, delta; response to stress), and
Loxl2 (lysyl oxidase like-2; apoptosis), which were significantly down-regulated, and Amph
(amphiphysin I; synaptic vesicle recycling), Parp2 (poly ADP-ribose polymerase-2; apoptosis),
and Cxcl12 (chemokine (C-X-C motif) ligand 12 or stromal cell derived factor-1 alpha;
chemotaxis), which were significantly up-regulated. We confirmed that each real-time RT-PCR
reaction resulted in only one product by determining the predicted melting point for each
amplicon and by confirming that this matched that obtained by melting curve analysis. We
further confirmed the presence of a single amplicon of the predicted size by agarose gel
electrophoresis. In all cases, the direction of change between the microarray data and the real
time RT-PCR data was the same, and the p-values for the real time RT-PCR were < 0.05 for all
except Loxl2, for which the p-value = 0.05 (Table 4.6).
The results of our analyses validate the use of the Harlequin mutant mouse model at the
cellular and molecular levels for fundamental studies of neurodegeneration in the murine
olfactory system and suggest mechanisms underlying this olfactory degeneration and associated
tissue remodeling.
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Table 4.6. Real-time RT-PCR validation of GeneChip data
Gene

GeneChip

GeneChip

Real-time

Real-time

Symbol

p-value

fold-

RT-PCR

RT-PCR

change

p-value

fold-change

Pdcd8

7.3E-05

↓4.7

2.0E-03

↓2.6

Cct4

1.3E-03

↓2.1

9.7E-03

↓1.3

Loxl2

2.9E-03

↓1.9

5.2E-02

↓1.4

Amph

4.9E-04

↑1.6

2.4E-02

↑1.2

Parp2

1.5E-03

↑1.6

4.0E-02

↑1.2

Cxcl12

2.8E-03

↑1.7

1.0E-04

↑1.5
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Discussion
In this paper, I have demonstrated the occurrence of oxidative damage to mOSNs and an
increase in apoptosis in the OE as a result of a single mutation in the Pdcd8 gene in the
Harlequin mutant mouse. Our bioinformatics analysis identified specific genes involved in
oxidative stress, apoptosis and other neurodegenerative processes that provided insight into the
underlying neurodegenerative mechanisms.
The protein product of the Pdcd8 gene, AIF, is a mitochondrial-resident flavoprotein
under non-apoptotic conditions (Hong et al. 2004).

In the OE of control mice, AIF

immunoreactivity was punctate in appearance and located primarily in the dendritic and
perinuclear regions of mOSNs, coinciding with the localization of mitochondria in mOSNs as
shown in electron microscopic studies (Naguro and Iwashita 1992). In contrast, most OSNs in
the Harlequin mutant mice lacked AIF expression. This result was anticipated based on a
previous report in which an 80% reduction in both the Pdcd8 transcript and AIF protein was
observed in the retina and various brain regions (Klein et al. 2002). The occasional clusters of
AIF-positive cells, many of which were mOSNs, in the OE of the Harlequin mutant mice
exhibited a very different sub-cellular localization pattern that appeared diffusely cytosolic. This
indicates that AIF protein was translocated out of mitochondria during the degenerative process
under conditions of oxidative stress.

AIF is key to maintaining mitochondrial oxidative

homeostasis under physiological conditions (Vahsen et al. 2004) and, in pre-apoptotic cells, it
may be translocated into the cytosol prior to entering the nucleus (Hong et al. 2004; Modjtahedi
et al. 2006).
Oxidative DNA damage occurs in mitochondria of aging neurons and those undergoing
neurodegeneration (Sullivan et al. 2004). The Harlequin mutation results in decreased levels of
AIF protein as well as substantially reduced oxidoreductase activity, leading to elevated
mitochondrial oxidative stress, identified by DNA damage in various brain regions (Klein et al.
2002; Stringer et al. 2004; Vahsen et al. 2004). Previous studies from our laboratory and others
have described the occurrence of oxidative macromolecular damage in the olfactory system in
aging and neurodegenerative disease, as shown by increased levels of protein oxidation,
including carbonylation, 3-nitrotyrosylation, and lipofuscin deposition, in the OBs of aging mice
as well as increased DNA damage in OSNs and OBs from Alzheimer’s disease patients (Getchell
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et al. 2003a; Perry et al. 2003; Poon et al. 2005b; Poon et al. 2006b; Vaishnav et al. 2006). In the
Harlequin mice, we found evidence for both protein and DNA oxidative damage.

The

accumulation of lipofuscin, a so-called “age pigment” of postmitotic cells that is a marker of
primarily undegradable oxidized protein (Keller et al. 2004; Terman et al. 2006), has been
previously observed in aging mice primarily in the foot processes of OE sustentacular cells and
in OB mitral/tufted cells (Naguro and Iwashita 1992; Vaishnav et al. 2006). I have demonstrated
a similar pattern of intense autofluorescent lipofuscin deposits throughout the OE, particularly in
the foot processes of sustentacular cells, as well as in mitral/tufted cells in the OBs of the
Harlequin mutant mice. I have also demonstrated the presence of elevated DNA damage, as
evidenced by increased 8OHdG, in mOSNs in the OE and in mitral/tufted cells of the OBs of the
Harlequin mice, as previously reported in the brains of Harlequin mice (Klein et al. 2002;
Stringer et al. 2004).

Taken together, the evidence that I have provided for oxidative

macromolecular damage in the OE and OB of the Harlequin mice that results from a single
mutation in the Pdcd8 gene make these mice an attractive model for studies of oxidative-stress
associated neural changes in the olfactory system.
Oxidative macromolecular damage predisposes neurons to cell death through the release
of pro-apoptotic factors, including AIF and cytochrome c, that activate caspase-independent and
caspase-dependent cell death pathways (Annunziato et al. 2003; Culmsee and Landshamer 2006;
Getchell et al. 2005; Holcomb et al. 1995). Caspase-3 and its active form cleaved caspase-3 are
key initiators of the apoptotic cascade in mOSNs as a result of oxidative stress and OBX
(Borders et al. 2006; Cowan and Roskams 2004; Cowan et al. 2001; Getchell et al. 2005).
Cleaved caspase-3 is an effector of neuronal apoptosis in the cerebellum and retina of Harlequin
mice as well as in neuronal cell culture models in which Pdcd8 is mutated (Cheung et al. 2006;
Klein et al. 2002). The marked increase in cleaved caspase-3-positive cells in the OE of the
mutant mice demonstrated that the Harlequin mutation can lead to apoptotic cell death in the OE,
possibly as a result of increased neuronal vulnerability due to oxidative DNA damage. The
increased numbers of macrophages in the OE of the Harlequin mutant mice (e.g., Figure 4.3) was
also indicative of increased numbers of apoptotic OSNs, which initiate a molecular cascade in
which chemokine release causes the infiltration of macrophages that phagocytose apoptotic
OSNs (Borders et al. 2006; Getchell et al. 2006; Getchell et al. 2002b; Kwong et al. 2004;
Suzuki et al. 1995). The changes in tissue architecture, as observed in hematoxylin and eosin-
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and α-laminin-stained sections, further demonstrate the degenerative changes occurring in the
OE that are similar to previous observations of cytoskeletal remodeling in the degenerating OE at
short time points post-OBX as reported by our laboratory (Getchell et al. 2006; Getchell et al.
2005; Nan et al. 2001).
The statistical analysis of our microarray data showed that the single gene mutation in
Pdcd8 resulted in highly significant changes in a select group of genes. Our categorical analysis
provided further confirmation that the mutation resulted in changes in several oxidative stressand neurodegeneration-associated genes in the OE. The majority of the genes regulated in the
Harlequin mutant mouse OE were involved primarily in oxidative stress, apoptosis/cell cycle,
and/or extracellular matrix/transport, complementing our cellular observations and supporting
our validation of the Harlequin mouse model for fundamental olfactory neurobiological studies.
From among the 221 genes significantly up- or down-regulated with p < 0.01 in the OE of the
Harlequin mice, I selected six genes for validation with RT-PCR; these genes were particularly
relevant to our cellular results showing increased oxidative stress, apoptosis, and
cytoarchitectural disruption.

Three of these genes (Pdcd8, Cct4, and Loxl2) were down-

regulated, and three (Amph, Parp2, and Cxcl12) were up-regulated; the direction and relative
magnitude of gene regulation in the microarray results were validated by the RT-PCR results.
Pdcd8 (GO category, apoptotic mitochondrial changes) was significantly down-regulated
by 80% in our microarray analysis, confirming our immunohistochemical data showing a
substantial reduction in the expression of AIF protein in the OE. Two other down-regulated
genes, Cct4 (GO category, unfolded protein binding) and Loxl2 (GO category, oxidoreductase
activity), are also related to stress responses and oxidative stress. Cct4 encodes the delta subunit
of the chaperonin-containing tailless complex polypeptide (CCT), a large (> 900 kD) multisubunit complex that mediates cytosolic protein folding (Dunn et al. 2001). The CCT4 subunit is
involved in binding to and folding cytosolic proteins such as the cytoskeletal proteins actin and
tubulin and several cell cycle-related proteins (Spiess et al. 2004). An autosomal recessive
mutation in Cct4 causes a hereditary peripheral sensory neuropathy in rats that is characterized
by pronounced apoptosis in the dorsal root ganglion and loss of cutaneous sensory fibers (Hsu et
al. 2004; Lee et al. 2003). Down-regulation of Cct4 in the OE may compromise the proper
folding of actin and tubulin, leading to disruption of cytoskeletal integrity, axonal transport and
pathway finding, and of cell cycle proteins, leading to decreased neurogenesis. The presence of
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improperly folded cytosolic proteins may induce additional oxidative stress (e.g., (Sitia and
Molteni 2004).

Loxl2 is a member of the lysyl oxidase (LOX) family that includes LOX,

LOXL, LOXL2, LOXL3, AND LOXL4 (Molnar et al. 2003). These copper-containing amine
oxidases, which are involved in extracellular matrix remodeling, cellular senescence,
development, and migration (Csiszar 2001), have been localized in Purkinje cells of the
cerebellum and in the retinal pigment epithelium and ganglion cells of the retina (Hayashi et al.
2004). Specifically, LOXL2 interacts with and stabilizes the transcription factor SNAIL, which
in turn down-regulates epithelial genes such as Cdh1 (cadherin 1, E-cadherin) and up-regulates
mesenchymal genes such as Vim (vimentin; (Peinado et al. 2005), both of which are key
molecules regulating the growth and axonal targeting of OSNs (Akins and Greer 2006a; Akins
and Greer 2006b). Also, regulation of a SNAIL homologue (Snai2) and Cdh1 have been
implicated in OE remodeling induced by OBX (Getchell et al. 2005). Consequently, a downregulation of Loxl2 in the OE of the Harlequin mice may be associated with increased apoptosis,
decreased neurogenesis, and/or cytoarchitectural changes in the tissue (Csiszar 2001; Molnar et
al. 2003; Peinado et al. 2005).
Among the validated genes up-regulated in the OE of the Harlequin mice, Amph (GO
category, synaptic vesicle endocytosis), which is particularly enriched in nerve terminals in the
brain and retina, encodes a key protein involved in clathrin-mediated endocytosis and synaptic
vesicle formation (Wigge and McMahon 1998).

AMPH is a member of the

Bin1/amphiphysin/Rvs167 (BAR) domain protein family (Ren et al. 2006), which is involved in
a variety of fundamental cellular processes and function by sensing the curvature of cellular
membranes and recruiting/activating GTPases (Ren et al. 2006). The main physiological ligands
for AMPH are dynamin (DNM1) and synaptojanin, with which it functions cooperatively in
clathrin-mediated endocytosis (Grabs et al. 2000; Yoshida and Takei 2005). The GTPase DNM1
is co-localized with clathrin in cell bodies, dendrites and dendritic knobs of OSNs (Rankin et al.
1999) and forms a stable complex with synaptojanin and endophilin 3 in the synaptic termini of
OSNs (Faire et al. 1992; Sugiura et al. 2004). We previously reported the identification and ageassociated down-regulation of DNM1 in murine olfactory bulbs and brains (Poon et al. 2005b;
Poon et al. 2006b) as well as the oxidative stress-associated carbonylation of this protein in
olfactory bulbs (Vaishnav et al. 2006). The down-regulation and likely impairment of DNM1
function that we have shown to result from oxidative stress may cause a compensatory up-
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regulation of Amph expression. Parp2 (GO category, DNA repair) encodes the nuclear enzyme
PARP2, which is one of 18 members of the poly(ADP-ribose) polymerase (PARP) superfamily
(Huber et al. 2004). PARP2 and its partner PARP1 detect oxidative stress-induced breaks in
DNA and initiate single strand break repair and base excision repair pathways by ADPribosylating DNA-binding proteins (Bouchard et al. 2003; Huber et al. 2004). If the damage to
DNA is extensive, PARP2 and PARP1 initiate apoptosis via the caspase-independent pathway by
triggering AIF release from mitochondria (Hong et al. 2004). Our laboratory has previously
reported the up-regulation of Parp2 in the senescence-accelerated mouse (SAM) model of aging,
and the localization and an apparent increase of PARP1 in olfactory nerve bundles in these mice
(Getchell et al. 2004). The up-regulation of Parp2 in the OE of Harlequin mutant mice was
consistent with the elevated neuronal DNA damage demonstrated by 8OHdG due to increased
oxidative stress.

Also, PARP2 activation may be responsible for initiating the cytosolic

translocation of AIF, resulting in the diffuse pattern of immunoreactivity that we observed in the
occasional clusters of AIF-immunoreactive OSNs in the Harlequin mutant mice. Cxcl12 (GO
category, cell migration) encodes the CXC motif-containing chemokine CXCL12 which is a
chemoattractant for a variety of immune system cells including monocytes (Blades et al. 2002)
as well as OB progenitor/stem cells (Tran et al. 2004). CXCL12, through its receptor CXCR4,
also plays a significant physiological role in the nervous system by guiding survival,
development, targeting and neurotransmission of several neuronal subtypes including retinal
ganglion cells, retinal pigment epithelial cells and cerebellar granule cells (Bhutto et al. 2006;
Klein and Rubin 2004; Li et al. 2005). Cxcl12 is significantly up-regulated at 48 h following
OBX, presumably as part of mechanism by which macrophages are recruited to the OE (Getchell
et al. 2006). In the OE of the Harlequin mutant mouse, the increased numbers of macrophages
that we observed may be due in part to the apoptosis-induced up-regulation of Cxcl12.
Our EASE analysis highlighted the cellular components involved and the biological
pathways which were downstream to the Harlequin mutation in the OE. An integrated picture
emerged from this analysis: the primary cellular components, in which a proportionately higher
number of genes were up-regulated, were the nucleus, endoplasmic reticulum, and mitochondria,
all three of which are major players in oxidative stress responses and apoptosis. Among downregulated genes, we found an over-representation of the categories of neurogenesis and
cytoskeletal organization, both of which are critical processes in the maintenance of the normal
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adult OE. Down-regulated neurogenesis has been reported in the OE, OB, and subventricular
zone in old rats and mice (Enwere et al. 2004; Loo et al. 1996); in the OE of the Harlequin
mutant mouse, decreased neurogenesis-related gene expression may reflect the oxidative-stressmodified environment, indicated by increased amounts of 8OHdG and accumulation of
lipofuscin, that has been postulated to account for reduced neurogenesis in the aged brain (Limke
and Rao 2003). We have previously reported the down-regulation of key cytoskeletal genes
indicative of cytoskeletal remodeling in response to OBX-induced OSN apoptosis (Getchell et al.
2005); in the OE of the Harlequin mutant mouse, the down-regulation of these genes might
reflect increased apoptosis as well as the apparent disorganization of the OE cytoarchitecture.
In summary, I have introduced and provided novel evidence validating the Harlequin
mutant mouse as a model for studies of oxidative stress-associated olfactory neurodegeneration
at the cellular and molecular levels.

The cellular studies demonstrated that the Harlequin

mutation in the Pdcd8 gene resulted in decreased levels and altered distribution of AIF protein in
mOSNs, increased oxidative DNA damage in mOSNs and other cells in the OE, an increased
number of OE cells undergoing apoptosis, and cytoarchitectural disorganization. Our molecular
studies confirmed the reduction in Pdcd8 expression in the OE and identified genes whose
significant differences in expression levels in the mutant and wild type mice contribute to and
result from elevated oxidative stress and apoptosis. These integrated cellular and molecular
analyses provide direction for future mechanistic studies using Harlequin mice as a model of
oxidative stress- associated olfactory neurodegeneration.
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CHAPTER FIVE
GENERAL DISCUSSION

The overall aim of our study was to gain fundamental insight into molecular events
associated with olfactory aging and neurodegeneration. The first specific aim was to test the
hypothesis that oxidative stress is associated with aging of the olfactory system. To address this
question, I performed a comparative proteomic analyses, using 2-dimensional gel
electrophoresis, of the olfactory epithelium (OE) and olfactory bulb (OB) of old (20-month old)
and young (1.5-month old) mice with further analysis of selected proteins at the mRNA level
using real-time RT-PCR. Nine proteins in the OE and 20 in the OB were differentially expressed
in old and young mice, demonstrating an altered proteomic profile of the aged murine olfactory
system. The proteins identified by mass spectrometry were classified under three broadlydefined functional categories (summarized in Figure 5.1A), namely (a) metabolism, (b)
transport/synaptic and (c) oxidative stress. The expression of a number of the identified proteins
differed at the protein level but not at the mRNA level, suggesting the involvement of posttranscriptional mechanisms of protein regulation. Protein, DNA/RNA and lipid oxidation and
consequent cellular damage can occur due to elevated oxidative stress.

While damaged

molecules can be repaired, replaced or removed from the affected cells in most tissues, the aging
brain has been shown to be particularly susceptible oxidative damage, partly due to the lack of
neuronal replacement and a decline in proteasomal activity in aging (Keller et al. 2004; Poon et
al. 2004a; Szweda et al. 2003). This can result in the accumulation of oxidized and inactive
proteins as insoluble aggregates inside the cell, further hindering cellular function (Keller et al.
2004; Szweda et al. 2003).

Whether protein oxidation is a key mediator of olfactory

degeneration, and if so, to what extent, was largely unknown, and formed the basis of my second
specific aim.
The second specific aim was to test the hypothesis that the olfactory system accumulates
oxidative

stress-mediated

macromolecular

damage

over

time,

predisposing

it

to

neurodegeneration. To address this aim, I used redox proteomics to quantify total and specific
protein carbonylation and identify differentially carbonylated proteins in OBs of 1.5- and 20-
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month old mice. While many recent advances have been made in the understanding of molecular
interactions in olfactory neurobiology using genomics platforms, the field has remained naïve to
proteomics prior to the results reported here. This study is the first to apply proteomics in the
aging olfactory system to identify differentially regulated proteins as well as proteins which have
been post-translationally modified. The novel results described showed that oxidative stressassociated protein damage is a key player at the molecular level in the cellular pathology
underlying olfactory aging. The identities of the oxidized proteins were of key metabolism,
transport/synaptic and oxidative stress-associated proteins, suggesting that these processes may
be altered in the aging olfactory system (Figure 5.1B). Two types of protein oxidation:
carbonylation and nitration were up-regulated with aging in the OB, demonstrating that there is
an imbalance in oxidant-antioxidant levels. Further, the observation of elevated lipofuscin in
OBs of old mice demonstrated that there was increased aggregation of proteins due to excessive
oxidation and/or inefficient removal of these damaged proteins. Up-regulation and oxidation of
the oxidative stress-response protein ferritin heavy chain corresponded with the increased
lipofuscin in mitral/tufted cells, occurring incrementally over time. Aldolase 1, an oxidized
protein, was localized in astrocytes of the granule cell layer. These results showed that specific
carbonylated proteins, including those in mitral/tufted neurons and astrocytes, and nitrated
proteins in the vasculature, are molecular substrates of age-related olfactory dysfunction.
Mitral/tufted cells, certain astrocytes and endothelial cells were targets of protein
oxidation in the OB. Interestingly, granule cells and periglomerular cells, both of which are
replaced by neurogenesis, did not appear to be directly affected by oxidative stress in our studies.
Mitral/tufted cells, in contrast, are amitotic and not replaced, which would explain the
accumulation of oxidized proteins over time. Nevertheless, I would not rule out the possibility of
reduced neurogenesis also occurring due to oxidative stress, and a detailed pulse-chase in-vivo
experiment could be designed in a follow-up study to assess changes in steady-state levels of
protein oxidation in various cell types over time. Further, cell-type specific antioxidant
responses, as well as protein clearance efficiency over time would have to be measured critically
in future studies.
In summary, the results from specific aims 1 and 2 clearly demonstrated the presence of
oxidative stress in the aging OB and identified specific protein and cellular targets of oxidative
damage.
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Figure 5.1.

Venn diagrams showing broadly-defined functional relationships of proteins

identified using proteomics. A, Proteins whose steady-state levels were significantly up- or
down-regulated in the OE/OB of 20-month old mice compared to 1.5-month old mice. B,
Proteins that were specifically carbonylated in the OBs of 20-month old and/or 1.5-month old
mice.
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The aging mice were raised in controlled, sterile, pollutant-free environments, so it may
be assumed that the only major factor differing between them and their younger cohorts was age.
Consequently, the majority of the oxidative stress experienced by these mice would likely be of
endogenous origin. Although other studies have evaluated the role of exogenous and endogenous
oxidants in the brain (Korolainen et al. 2002; Perluigi et al. 2005; Pocernich et al. 2005; Poon et
al. 2006b; Sultana et al. 2005) and the olfactory system (Perry et al. 2003), our current study is
the first to systematically identify the proteins oxidized by endogenous oxidative stress in the
olfactory system. Future studies using the proteomics platform to identify and characterize
proteins oxidized in olfactory system due to exogenous oxidants would be an excellent
complement to the work described here.
With progressive oxidative stress-associated protein damage clearly emerging as a
hallmark of aging in the olfactory system, the third specific aim was to test the hypothesis that
elevated oxidative stress in the olfactory system results in apoptosis/neurodegeneration. To
successfully address this aim, we needed to identify a mouse model exhibiting elevated
endogenous oxidative stress. Majority of the endogenous oxidants known are by-products of
normal mitochondrial metabolism, and their levels increase as mitochondrial efficiency declines
with aging (Sastre et al. 2003). The mitochondrial/free radical theory of aging proposes that
elevated oxidative stress is a causative factor of the neurodegenerative changes associated with
aging as well as age-associated disorders like Alzheimer’s disease (Pollack and Leeuwenburgh
2001; Sastre et al. 2003). The Harlequin mouse, in which a defined mutation in a mitochondrial
protein results in a dramatic decrease in mitochondrial metabolic activity, associated elevated
oxidative stress and progressive neurodegeneration (Culmsee and Landshamer 2006; Klein et al.
2002; Vahsen et al. 2004), was chosen for our study of the effects of elevated
physiological/endogenous oxidative stress in the olfactory system. Here, I have reported the first
characterization of the Harlequin mouse as a model for olfactory neurodegeneration associated
with elevated oxidative stress, apoptosis and cytoskeletal reorganization occurring as early as 6
months of age.
The Harlequin mutant mouse carries an X-linked recessive mutation in the Pdcd8 gene
(Hq mutation) and is a model of progressive oxidative stress-induced neurodegeneration in the
cerebellum and retina (Klein et al. 2002). To determine whether the Harlequin mutant mouse
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would be a suitable model of oxidative stress-associated olfactory neurodegeneration, we
investigated cellular and molecular changes in the OE of 6-month old male Harlequin mice
compared to their littermate controls.

Pronounced cytoskeletal changes, including laminar

disorganization, were evident in the OE and to a lesser extent in the OB.

Punctate

immunoreactivity for the protein product of Pdcd8, apoptosis-inducing factor (AIF), was
localized in dendrites of mature olfactory sensory neurons (mOSNs) in control mice but was
seldom detected in Harlequin mice, as expected. The Harlequin mice also exhibited increased
immunoreactivity for the oxidative DNA damage marker 8-hydroxydeoxyguanosine in mOSNs,
increased number of apoptotic cells in the OE, and increased macrophage infiltration. The
cellular results were confirmed and extended by microarray analysis, demonstrating that Pdcd8
mRNA expression was down-regulated 80% in the OE of Harlequin vs. control mice. Most of
the significantly regulated genes were functionally classified into oxidative stress, apoptosis/cell
cycle and/or extracellular matrix/transport-associated categories.

Bioinformatics analysis

indicated that significantly over-represented functional categories in Harlequin mice included upregulated mitochondrial genes, and down-regulated cytoskeletal organization- and neurogenesisrelated genes.
Mechanistically, the Harlequin mouse has given us considerable insight into the events
underlying oxidative-stress associated olfactory degeneration. The model shown in Figure 5.2 is
an illustration of the mechanism I have proposed, by which the Hq mutation, resulting in
decreased AIF and mitochondrial impairment, interacts with progressing age to promote
increased oxidative stress-associated oxidative DNA and protein damage and apoptosis of
olfactory sensory neurons. As illustrated in Figure 5.2, AIF is expressed in mitochondria in the
dendrites and supranuclear region of mOSNs in healthy control mice and is down-regulated by
80% in Harlequin mouse OE due to a mutation in the Pdcd8 gene. Consequently, mitochondria
would be less efficient, resulting in an increase in mitochondrial oxidative stress and associated
DNA damage. Interestingly, the DNA damage observed in the 6-month old Harlequin mouse OE
was primarily in the mitochondria, mainly in the mOSNs. Lipofuscin aggregates, typifying
excessive protein oxidation, were also present throughout the OE of the Harlequin mice. The
oxidative DNA and protein damage observed in Harlequin mouse mOSNs would suggest an
increase in their susceptibility to apoptotic cell death. Certain mOSNs in the Harlequin mouse
OE exhibited diffuse cytosolic AIF immunoreactivity, suggesting translocation of AIF out of the
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mitochondria in response to elevated oxidative stress and DNA damage. AIF may partner with
PARP2 (the mRNA for which was significantly up-regulated in the Harlequin mouse OE) and
PARP1 to initiate caspase-independent apoptosis if DNA damage were extensive; or could be
sequestered in the cytosol by HSP70 to allow for DNA repair and cell survival. The concurrent
occurrence of frequent of cleaved-caspase-3 positive cells in the OE of the Harlequin mice
demonstrated that caspase-dependent mechanisms of apoptosis were being activated in parallel.
Figure 5.3 expands on our model in Figure 5.2, to include the cross-cellular communication
between mOSNs, macrophages and mitral/tufted cells and illustrate the postulated roles of the
protein products of significantly regulated genes selected from our microarray study. Lower
levels of available chaperonin, as indicated by down-regulated Cct4, would be another
contributing factor to the oxidative stress-associated protein aggregation observed in the OE/OB.
In addition, macrophage/microglial infiltration was observed in both the Harlequin mouse OE as
well as the OB, possibly functioning to scavenge apoptotic olfactory neurons, including mOSNs.
The chemokine CXCL12, which is known to be secreted by macrophages could be another key
player in determining the fate of mOSNs, namely, survival vs. death. Synaptic communication
between mOSNs and mitral/tufted cells, may also be hindered, with several key synaptic genes
(e.g. amphiphysin) among the significantly regulated genes. The down-regulation of the growth
and axonal targeting-associated Loxl2 would further impair cross-cellular communication and
result in increased apoptosis, decreased neurogenesis, and/or cytoarchitectural changes in the
tissue
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Figure 5.2. This working model summarizes the sequence of events through which diminished
AIF expression in Harlequin (Hq/Y) mice results in elevated oxidative stress and apoptosis in
mature olfactory sensory neurons. +/Y, littermate control; AIF, apoptosis inducing factor;
PARP1 and PARP2, poly(ADP-ribose) polymerase 1 and 2; HSP70, heat shock protein 70kD.

127

FTH
DNM1
AMPH

AMPH

DNM1

FTH

FTH

CCT4

LOXL2

APOPTOSIS

CXCL12

CXCR4

MФ

SURVIVAL

HSP70

AIF

PARP1
PARP2

AIF

AIF

Lipofuscin

CXCL12

MФ

MФ

AMPH

Mitral cell

Microglia

Lipofuscin

Oxidative stress

DNA Damage (8OHdG)
Oxidative stress

DNA Damage (8OHdG)

Hq/Y
mOSN

Figure 5.3. The schematic summarizes the molecular pathways identified in the Harlequin
mouse olfactory system in this study and their likely roles in survival vs. cell death decisions for
mature olfactory sensory neurons (mOSNs). Italicized symbols, proteins down-regulated at the
mRNA level; non-italicized symbols, proteins up-regulated at the mRNA level; MФ,
macrophage; AIF, apoptosis inducing factor; LOXL2, lysyl oxidase like-2; CCT4, chaperonin
containing t-domain 4; PARP1/2, poly(ADP-ribose) polymerase 1/2; CXCL12, CXC-containing
chemokine 12; AMPH, amphiphysin; DNM1, dynamin 1; FTH, ferritin heavy chain 1; HSP70,
heat shock protein 70.
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The Harlequin mice exhibit clear tissue- and cell-type specific phenotypic differences in
oxidative damage and apoptosis, possibly due to a difference in sensitivity to the Hq mutation.
This was also evident in the study reported by Klein et al, in which retinal and cerebellar
degeneration occurred at temporally distinct stages in various cell types (Klein et al. 2002).
Furthermore, while progressive oxidative damage and cell death were clearly observed by Klein
et al and confirmed by our group in the retina and cerebellum of the adult Harlequin mice,
evidence of degenerative changes was less obvious in most other regions of the brain (Klein et
al. 2002). Other studies have reported that all brain regions of the Harlequin mice, both the
degenerative and the apparently protected regions, demonstrated oxidative DNA damage
(Stringer et al. 2004), suggesting that differences in antioxidant defense, DNA damage repair and
protein clearance systems may play a major role in the cell- and region- specific phenotypes
observed.
The degenerative changes observed in the olfactory system of Harlequin mice had certain
similarities to, but several major differences from those in normally aging mice. The occurrence
of oxidative stress-associated macromolecular damage was the overall commonality between the
two. This was highlighted by the occurrence of increased lipofuscin deposits in mitral/tufted cells
in the OB and in the foot processes of sustentacular cells in the OE of Harlequin mice as early as
6 months, which were similar in intensity to those observed in the 20-month old aging mice. Yet,
differences were also evident, including the lack of increase in ferritin heavy chain in the
mitral/tufted cells in the Harlequin mice, possibly indicating a compromised antioxidant
response. This would help explain the occurrence of elevated DNA damage in the mitral/tufted
cells of Harlequin mice. Also, in addition to their occurrence in the sustentacular cell foot
processes, intense lipofuscin deposits were scattered throughout the OE layers in the Harlequin
mice, indicating more widespread oxidative damage than in normally aging mice.

Other

differences noted included increased number of apoptotic cells in the OE and marked
cytoarchitectural changes in the OE and the OB of the Harlequin mice, both of which were far
more dramatic in the Harlequin mice than in the normally aging mouse olfactory system.
Collectively, the results of this dissertation suggest that age-associated oxidative stress
causes damage to key macromolecules, and, in combination with other factors (such as the Hq
mutation), can to lead to neurodegeneration. These conclusions can be extrapolated to the “real
world”, where aging would be accompanied by cumulative oxidative macromolecular damage
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due to mitochondrial metabolic decline; oxidative damage would be accelerated by exogenous
oxidants such as chemical pollutants contributed by the environment; and finally, the genetic
component would serve as the “third hit” in determining the fate of an individual by either
protecting or predisposing it to further degeneration and possibly neurodegenerative disorders.
While the first two components would accompany normal aging and individual lifestyle, the
third (genetic) component would determine the individual’s inherited vulnerability (e.g. as in the
Harlequin mouse).
Apart from the clearly significant contribution this study has made to the basic
understanding of olfactory degeneration, the results also provide direction for future mechanistic
studies and clinical applications. The lack of timely, accurate and simple diagnostic tests to
detect the onset and monitor progress of age-associated neurodegenerative diseases such as
Alzheimer’s and Parkinson’s disease warrants the development of minimally-invasive, sensitive
and specific biomarker assays. The identification of differentially regulated genes and proteins,
which are specific to a disease, in biopsies of the OE or OB, would provide a platform for such
diagnostic tests. Further, since specific proteins undergo post-translational modification by
protein carbonylation, and can be identified reliably using the proteomics methodology described
here, such protein-specific modifications could serve as a second tier of markers for
differentiating disease conditions. Finally, since olfactory sensory decline coincides with early
(pre-cognitive decline) Alzheimer’s disease, for which reliable early diagnostic tests remain
elusive, the careful design of such a biomarker assay could provide a method for predicting the
likelihood of future onset of this disease in an individual, allowing for timely medical
intervention.
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CHAPTER SIX
CONCLUSIONS AND FUTURE DIRECTIONS
The results described in my dissertation provide evidence for oxidative stress-mediated
molecular and cellular changes in murine olfactory aging and neurodegeneration.

Several

molecular targets of oxidation were identified in the aging olfactory system. The functional
consequences of oxidation for each individual protein and its impact on the aging olfactory
epithelium and bulb remain to be investigated and provide interesting testable hypotheses. For
example, the lipofuscin-associated mitochondrial respiratory chain protein ATP5A1 both
accumulated in the aging olfactory bulb and was specifically carbonylated.

One could

hypothesize, based on the results described here and what has been reported in literature, that
mitochondria are specific targets of oxidation in the olfactory bulb, and possibly contribute to the
cellular debris consisting of dysfunctional proteins and damaged organelles in aging.
In this dissertation, I have demonstrated the progressive accumulation of markers of
oxidative damage in the normally aging olfactory system. The 6-month old Harlequin mouse also
showed elevated oxidative damage compared to age and gender-matched littermate controls.
The validation of the Harlequin mouse in this dissertation as a model for oxidative stressmediated olfactory neurodegeneration supports the design of future studies on a larger scale to
investigate progressive changes occurring in the olfactory system of the Harlequin mutant mice.
It would be of interest to investigate not only the progressive cellular changes, including
oxidative damage, but also temporal changes in the genes and pathways identified as being
altered in the olfactory system of 6-month old Harlequin mutant mice.
Finally, this dissertation has identified cellular targets of oxidative stress in the olfactory
system, including mitral cells, astrocytes and olfactory sensory neurons. Future studies could
investigate the functional consequences of oxidative stress in the cellular targets identified here.
Using this study as a platform, there are many directions that future research could take to
investigate the molecular and cellular changes in olfactory aging and neurodegeneration. I have
given some examples here and hope they will spark the imagination and creativity of future
investigators, realizing that in science there can be boundless directions leading to many
discoveries which remain unforeseen.
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